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ABSTRACT 
The researcher investigated the knowledge, attitudes and experiences of people 
living with the Human Immunodeficiency Virus (HIV) towards antiretroviral treatment 
(ART) and who are accessing antiretroviral treatment at a public health clinic in 
Limpopo, South Africa. A qualitative method was used. The research findings 
revealed five themes: experiences, social support, knowledge, attitudes, 
unemployment and economic themes of the study. Factors reported influencing 
optimum adherence were the inability of the patients to take medication at work, 
laziness of the patients to collect medication, unemployment, economic hardship, 
poverty and lack of knowledge of employers regarding HIV/AIDS. 
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CHAPTER 1 
 
OVERVIEW OF THE STUDY 
 
1.1. INTRODUCTION 
This study investigates the knowledge, attitudes and experiences of people living with 
the Human Immune Virus (HIV) and who are on antiretroviral treatment (ART). This 
chapter presents a background to the study undertaken. It provides information on the 
focus area of the study and it outlines the research problem and the ARV roll-out 
programme initiated by the South African National Department of Health. In addition, 
it also outlines the aims and objectives of the study and the research questions to be 
answered by the findings. The definitions of key terms are provided in this chapter 
and a brief outline of the different chapters of this dissertation is given. It is anticipated 
that the findings and recommendations of the study would be shared with the 
Limpopo Provincial Health Senior Management, in-cooperated into training 
workshops and be shared with Health Care Workers (HCW) in the province.  
1.2. BACKGROUND TO THE STUDY 
The South African government recognizes that the country has a very high burden of 
infection, with an estimated 6.4 million people living with HIV by the end of 2012. 
(HSRC 2012). In addition, South Africa’s landscape of the national HIV epidemic has 
improved dramatically since 2001. South Africa has reduced new HIV infections by 
41% between 2001 and 2011 (UNAIDS 2012). However, as the South African 
government enters the final years of achieving the Millennium Development Goals in 
2015, much remains to be done to reach the targets. A number of government 
interventions and strategies have been put in place over the years to reduce the HIV 
infection rates in the country. The programmes such as the HIV Counseling and 
Testing (HCT) awareness campaign established in 2010 (NDOH 2010), the increased 
call for condom use and distribution, HIV and sex education in all sectors of the 
society, and the medical male circumcision programmes were all aimed at reducing 
HIV infection.  
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According to the HSRC (2012), the launch of the national HIV counseling and testing 
(HCT) campaign in April 2010 resulted in a remarkable increase in the number of 
people accessing testing. It is further indicated by the HSRC (2012) that between 
2008 and 2012, annual HIV testing increased from an estimated 19.9% to 37.5% 
among men, and from 28.7% to 52.6% among women. South Africa has the largest 
antiretroviral treatment (ART) roll-out programme in the world, achieving a 75% 
increase in HIV treatment services between 2009 and 2011 (UNAIDS 2012). By 
October 2012, over two million people were receiving ART, surpassing the country's 
universal access target of 80% in accordance with the 2010 World Health 
Organization (WHO) treatment guidelines and offering treatment to people with a CD4 
count under 350 (WHO 2010). 
According to the National Department of Health (NDOH), the government is 
committed to ensuring universal access to antiretroviral therapy in order to improve 
the quality of lives and the country outcomes (Jones, 2009). According to Saleh 
(2012), the national ART roll out programme for South Africa requires human 
resources, financial planning and monitoring and evaluation systems, as well as 
institutional capacities.  
For ART to be able to attack and suppress viruses, patients must adhere to treatment 
for life. Not following instructions to take medication, collecting medication and not 
taking it and missing out on doses will lead to drug resistance and to the medication 
not to work (Abdool & Karim 2010). Keeping patients on an ART programme needs 
commitment from all stakeholders, patients, family, programme managers, wellness 
clinic staff and political leaders. Furthermore, optimal adherence to ART has the 
potential for turning an HIV infection from an acute illness to a manageable chronic 
disease such as Diabetes and Hypertension.  
The South African national ART programme was conceived to reduce and meet the 
high burden of infection that the country experiences (NDOH 2014). South Africans 
hope for a good quality of life for people living with HIV and in need of ART when the 
Operational Plan for Comprehensive HIV and AIDS Care, Management and 
Treatment for South Africa was approved by the National Department of Health in 
2003 (NDOH 2003).  
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The National Department of Health’s antiretroviral treatment revised guidelines state 
that adults and adolescents are eligible for ART if they meet medical criteria and 
psychosocial considerations (NDOH 2015). Furthermore, it means that the patients 
should meet these criteria to be able to start the treatment; the patient should be 
psychologically and medically ready to start ART, because ART is not an emergency.    
According to NDOH (2015:48) the eligibility criteria for ART initiation have been 
revised to increase access to treatment, with effect from 1st January 2015. The 
medical criteria include children under the age of 5 years old, Adolescents and Adults 
with CD4 of < 500 cells/mm3 or a diagnosis of WHO stage 3 and 4 diseases, 
irrespective of CD 4 count or WHO staging.  
Furthermore, there is the psychosocial consideration that patients should have 
attended three or more scheduled visits, no active alcohol or substance abuse, 
disclosed of HIV status to at least one family member or joined support group and is 
able to visit the treatment centre on a regular basis (NDOH 2015:41). 
Ross, Weinstein and Schackman (2015:1159) state that strict adherence to 
antiretroviral therapy (ART) is the key to sustained HIV suppression, reduced risk of 
drug resistance, improved overall health, quality of life, and survival. In addition, poor 
adherence to antiretroviral medication accelerates the development of drug resistant 
HIV, whereas without adequate adherence, antiretroviral agents are not maintained at 
sufficient concentrations to suppress HIV replication in infected cells and to lower the 
viral load. 
According to Lyimo, De Bruin and Van den Boogaard (2012:716), it is important to 
identify and address challenges to complete adherence when starting ART, because 
adherence is such an important part of the treatment. It is clear that adherence is a 
cornerstone of a successful ART programme.  
It can promote retention of patients on ART for longer periods and the attainment of 
optimal health. The NDOH (2011) emphasizes the importance of adherence and 
suggests having a communication strategy that includes daily adherence reminders 
and re-adherence counseling at every clinic visit. 
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1.3. CONTEXTUALISATION OF THE RESEARCH PROBLEM 
According to Mayosi, Lawn and Van Niekerk (2012:2029), the HIV and AIDS 
pandemic has been one of the most challenging health issues that the South African 
government has had to deal with. Furthermore, HIV and AIDS pose a serious threat 
to the social and economic development of the country.  
In addition, South Africa has only 0.7% of the world population but is carrying 17% of 
the HIV and AIDS burden of the world. Adherence to ARV therapy is essential to 
maintaining long-term health benefits, and avoiding the development of viral 
resistance. Kaposhi, Mqogi and Schopflocher (2015:547) indicate that there is a need 
for strong support systems for PLHIV and that systems should be established within 
the facilities that render comprehensive care management and treatment of PLHIV, 
including ART. According to Kaposhi, Mqogi and Schopflocher (2015:547), 
counsellors trained on the ART programme could facilitate the establishment of 
support groups for people taking ART as their chronic medication and to reinforced 
community-based structures. People living with HIV and on ART have to be 
encouraged to identify social support structures in their communities and to disclose 
their HIV sero-status, as these factors directly impact on the success of an ART 
programme. Antiretroviral medication regimes for HIV infection are complex and 
inconvenient to PLHIV. They often produce side-effects and must be taken for long 
periods (Cummings, Gutin and Jailantilal 2014:602). 
Peltzer et al. (2012:218) indicate that the minimum level of adherence required for 
ARVs to work efficiently is 95%. Furthermore, important socio-economic predictors of 
ART adherence include transport and access to health service. It is important for the 
patients to take seriously the issues of adherence and commit to their treatment for 
the ART programme to be a success.  Dunbar-Jacob, Schenk and Mc Call (2012:271) 
report that failure to adhere to treatment satisfactorily leads to complications or 
progression of varied diseases. According to Dewing, Mathews and Lurie (2015:342) 
barriers to adherence included fear of disclosure, forgetfulness, health illiteracy, 
financial constraints and patients being away from their medications.  
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1.4. MOTIVATION FOR THE STUDY 
The researcher observed the high defaulter (lost to follow up (LTFU) rate of people 
taking ART while working at Witpoort Hospital despite the fact that the clinic has ART 
treatment guidelines and the criteria for starting ART are readily available. The 
researcher worked as the Deputy Manager Dietetics in the hospital and ART patients 
were referred to me from the clinic on monthly basis for nutritional assessments and 
follow up. It was during the researcher work at the hospital that he noticed the high 
number of patients who did not return for follow up medication. 
The researcher developed the interest in HIV and AIDS and the ART programme 
available to those suffering from the disease while working at the hospital. The topic 
of this research was motivated by nutritional counseling sessions the researcher 
conducted and experiences of working with people living with HIV (PLHIV) in the 
clinic. The findings that will be generated by this study will make a contribution to the 
understanding of what people living with HIV know about ART, their attitudes and 
experiences towards ART. In addition, the results will also contribute to the 
understanding of non-adherence and be useful in developing interventions that will 
take account the problems faced by people living with HIV and who are on ART at a 
public health clinic, in Limpopo, South Africa. People living with HIV and who are on 
ART are the key role players in the success of this treatment. An understanding of the 
patients’ knowledge, attitudes and their experiences may contribute to the 
implementation of strategies that would improve their adherence rate and reduce the 
number of challenges they face with this treatment.   
People living with HIV who are on treatment face many challenges such as non-
adherence, insufficient ART knowledge, avoidance of re-infection, poor or no 
adherence to therapy, lack of psychosocial support, stigma attached to the ART 
programme, poor access to treatment, long waiting times in the clinic, poverty and 
hunger and transportation. The government should find a way to address these 
issues for an ART programme to be a success. All these challenges may lead to poor 
uptake of ART, poor adherence and ultimately development of treatment resistance to 
patients and even death.   
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1.5.      PROBLEM STATEMENT 
South Africa is currently experiencing one of the most severe HIV and AIDS 
epidemics (UNAIDS 2012). By the end of 2012, there were approximately 6.4 million 
people (adults and children) living with HIV in the country (IRIN 2012). In the same 
year, 270,190 people died of AIDS related causes, 100,000 fewer than in 2001 
(UNAIDS 2012). One of the most effective ways to treat HIV/AIDS is taking the ART 
medication. However, ART is a lifelong treatment and there have been challenges to 
the implementation of the ART in Limpopo Province.  
Although ART is available and prescribed to those who need it and are eligible for it in 
South Africa, it seems that people on ART often do not comply with the treatment 
regimen due to a number of challenges, such non–adherence, knowledge of ART, 
side effects and they are lost to follow-up (Leach-Lemens  2010).  
1.6. AIM OF THE STUDY 
The aim of this study was to assess the knowledge, attitudes and experiences of 
people living with HIV and who are on antiretroviral treatment (ART) at a public health 
clinic in Limpopo, South Africa. 
1.7.  OBJECTIVES OF THE STUDY 
The following objectives were formulated to guide this study. The researcher wanted 
to: 
 assess the knowledge that people living with HIV have on ART. 
 identify attitudes of people living with HIV towards ART. 
 discover the experiences of people living with HIV and on ART. 
 identify the economic factors that support people living with HIV who are on ART. 
 identify the social factors that support people living with HIV who are on ART. 
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1.8. ASSUMPTIONS 
In this study in-depth interviews were conducted with selected patients living with HIV 
and who were on ART for more than six months. 
The assumptions in this study were that: 
 Not all people living with HIV who on ART have a good knowledge of ART. 
 Not all people living with HIV and on ART have negative attitudes towards ART. 
 Not all people living with HIV have bad experiences with ART. 
 
1.9. THE RESEARCH QUESTIONS 
The research questions were as follows: 
 What knowledge do PLHIV have on ART? 
 What are the attitudes of PLHIV towards ART? 
 What are the experiences of PLHIV on ART?  
 What are the economic factors that support people living with HIV and are on 
ART? 
 What are the social factors that support people living with HIV who are on ART? 
1.10. DEFINITIONS OF KEY CONCEPTS 
For the purposes of this study, the following key concepts were as follows: 
1.10.1. Knowledge 
Machlup (2014) defines knowledge as familiarity with something, which includes 
facts, information, descriptions, or skills acquired through experience or education. It 
is also indicated that knowledge acquisition involves complex cognitive processes 
such as perceptions, communication, association and reasoning, and that knowledge 
is related to the capacity of acknowledgement in human beings. In this study, ART 
knowledge among people taking ART would mean knowledge of resistance, 
adherence and side effects as well as the ability of people on ART to correctly clarify 
myths and misconceptions about ART. 
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1.10.2. Attitude 
 
According to Russell and Elsenberg (2012:203), attitude is defined as “a 
psychological tendency that is expressed by evaluating a particular entity with some 
degree of favor or disfavor. This definition encompasses the key features of 
attitudes—namely, tendency, entity (or attitude object), and evaluation. In this study, 
attitudes would mean negative or positive attitudes towards ART.  
1.10.3.    Experience 
 
According to Tsonis, (2012:1) experience is defined as an individual’s subjective 
experience of taking a medication (ART) in his/her daily life. It is an encounter that is 
given meaning before it happens and is often a reaction to the symbol that medication 
holds. In addition, It is also the knowledge of an event or a subject gained through 
involvement of exposure. 
1.10.4.  Antiretroviral Treatment (ART) 
 
Thompson, Aberg and Hoy (2012:387) state that ART is an acronym for Antiretroviral 
Treatment and refers to all drugs developed to prevent the HIV from replication. 
These drugs do not kill the HIV, but prevent it from multiplying (Wilson, Maartens, 
Cotton, Venter, and Bekker & Meyers 2002:332). These ART drugs improve the 
quality of life of people living with HIV. 
1.10.5. Human Immunodeficiency Virus (HIV) 
 
HIV is an acronym for Human Immunodeficiency Virus. In case of an infection with 
the HIV, it kills the defense mechanisms of the human being and the person becomes 
vulnerable to opportunistic infections (Wilson, Maartens, Cotton, Venter, Bekker 
2002:3, Thompson, Aberg and Hoy  2012:387). 
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1.10.6. Public Clinic 
 
Public Clinics are clinics that the National Health Department has established to 
provide HIV and AIDS-related services, including the rolling-out of ARV’s to the 
people infected with HIV and in need of ART (NDOH 2003) 
1.11. OUTLINE OF THE STUDY REPORT 
The following sections indicate the general outline and organization of the study 
report. 
Chapter 1  
This chapter presents an overview and background of the research. 
Chapter 2 
The second chapter reports on the literature review and explores on ART knowledge, 
attitude and experiences among people living with HIV and is on ART. The literature 
review focuses mainly on ART knowledge, attitude and experiences and presents the 
conceptual framework that has guided the study. 
Chapter 3 
The third chapter reports the outline of the methodology and design. The study 
respondents and sampling technique, the process of data collection and analysis, as 
well as the ethical consideration in the research are defined and discussed in this 
chapter. 
Chapter 4 
The fourth chapter presents the research findings and discussion and gives the 
analysis and interpretation of the study results. Here, the findings are clustered into 
five themes. Each theme is briefly defined, followed by direct quotations that provide 
support and clarity on the theme. 
Chapter 5 
The fifth chapter presents the discussion and conclusions drawn from the study as 
well as the limitations of the study.  
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In addition, recommendations based on the findings of the research are formulated. 
Linkage of the literature and the results are also discussed in this chapter. 
1.12. CONCLUSION 
 
In this chapter, the overview, motivation and objectives of the study were outlined. 
The chapter further outlined the problem statement; key terms used in the study were 
defined. The dissertation layout was presented. The next chapter presents a review of 
literature on the knowledge, attitude and experiences on people living with HIV and is 
on ART.  
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CHAPTER 2 
LITERATURE REVIEW 
2.1   INTRODUCTION 
 
In order to locate this study in terms of other studies on knowledge, experiences and 
attitudes of PLHIV who are on antiretroviral treatment (ART) and the relevant 
theoretical perspectives, literature from a wide range of international and national 
academic journals, online publications and other sources have been consulted. The 
focus in this chapter is on HIV and AIDS in Sub-Saharan Africa, on South Africa and 
the Limpopo Province, on the ART programme implementation in South Africa, its 
benefits and challenges, on the definition of the concept of adherence and 
identification of the factors for poor adherence, on the discussion of knowledge, 
attitudes and experiences concerning antiretroviral treatment of PLHIV and an 
exploration of a health seeking behavior model and its relevance to ART adherence. 
2.2.   HIV AND AIDS IN SOUTH AFRICA 
 
The NDOH (2014) indicates that public sector antiretroviral provision has had a slow 
start in South Africa due to political denials despite a raging epidemic and a World 
Aids Conference that shed a light on the disparities of therapy access globally. 
In addition, Lalloo and Pillay (2013:132) indicate that South Africa has the largest 
number of people living with HIV (PLHIV), estimated at 6.4 million, and by far the 
largest number of people on antiretroviral therapy (ART) in the world: almost 
2.5 million have started ART in South Africa with a total population of 54 million 
people. Besides the logistical challenges that a programme of this scale presents, the 
expanding number of people requiring treatment poses significant resource 
challenges (UNAIDS 2012). 
Following a troubled period, in which the South African government failed to come up 
with an appropriate treatment plan and which was accompanied by wide controversy 
and active campaigning within civil society, the government announced a gradual 
ART roll-out in 2003 (NDOH 2003). South Africa’s decision to start offering ART at 
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facilities and committing itself to fighting the disease has brought some relief after its 
long-standing indecisiveness on this issue.  
According to the WHO (2013), there are between 1.6 and 2.0 million additional PLHIV 
eligible for ART initiation at CD4 T-cell counts of < 500 based on the 2015 WHO 
Antiretroviral Treatment Guidelines (NDOH 2015).  
In addition, WHO (2013) indicates that between 300,000 and 500,000 people have 
become infected annually over the past decade, while the capacity of the National 
Department of Health system to start people on ART has expanded by only 20%.   
It is difficult to overestimate the suffering that HIV has caused in South Africa. Not 
only the person living with HIV in South Africa - or in any other country - are affected, 
but also their families, friends and the wider community. However, after years of 
controversial AIDS treatment history and the refusal of the South African government 
to provide ART to people living with HIV in South Africa, the South African 
government finally announced its approval to start offering ART in 2004 (UNAIDS 
2012).  
According to the NDOH (2013), treatment programmes have access to medication 
choices and monitoring that is in line with international guidelines, with the most 
recent improvements including fixed dosed combination (FDC) ART, including 
treatment for pregnant and lactating women and access to salvage regimens as 
reflected in the government HIV treatment guidelines.  
According to HSRC (2012) it is estimated that 12.2% of the population (6.4 million 
persons) were HIV positive, which is 1.2 million more PLHIV than in 2008 (10.6%, or 
5.2 million).  
2.3.  HIV AND AIDS IN THE LIMPOPO PROVINCE 
 
According to NDOH(2012), the National Antenatal Sentinel HIV and Syphilis 
Prevalence Survey (2012) shows that the Limpopo Province is seven-highest in terms 
of HIV prevalence in the country, after six other provinces such as KwaZulu-Natal, 
Mpumalanga, Freestate, North West, Eastern Cape and Gauteng (NDOH 2013).  
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The report further indicates that Limpopo is amongst the few provinces that have 
shown an increase in the overall prevalence rate, that is, from 8.8% in 2010 to 9.2% 
in 2012. The Limpopo Province has five District Municipalities, the Capricorn, 
Vhembe, Mopani, Sekhukhune and Waterberg Districts. 
It borders on Gauteng, the North West, Mpumalanga Provinces, the Republic of 
Mozambique, Zimbabwe and Botswana. There is a lot of migration to and from these 
neighboring countries and provinces. Dr. Mabasa (2013), the MEC for health in 
Limpopo province indicated that the Waterberg District (under which the chosen 
research site falls) continues to be the highest in new HIV infections in the Limpopo 
Province estimated at 30.3% at the end of 2012. This high rate of infections in the 
Waterberg District is attributed to high numbers of migration of contract workers in the 
Lephalale Local Municipality (Mabasa 2013). The ART programme implementation in 
the province was a call from National Department of Health for all hospitals in the 
country to be accredited to offer ART services (NDOH 2004).  
2.4.  SOUTH AFRICAN NATIONAL ANTIRETROVIRAL TREATMENT 
 PROGRAMME 
 
South Africa has the largest antiretroviral treatment (ART) programme in the world 
and has made significant strides in improving ART coverage (UNAIDS 2012). The 
South African government, with the assistance of international funders and non-
governmental organizations (NGOs), has managed to roll out a very effective ART 
programme since 2004 free of charge to the people living with HIV (PLHIV). At the 
end of 2009, an estimated 37% of infected people were receiving treatment for HIV 
(WHO 2010). In mid-2011, following the launch of the HIV Counseling and Testing 
(HCT) campaign by the SA National Department of Health in early 2010, it was 
announced that the number of people on ART had increased significantly from 
923,000 in February 2010 to 1.4 million in May 2011 (AVERT 2011). However, HRSC 
(2012) reported that South Africa has reached a target of universal access to 
treatment with 2 million people initiated on ART by October 2012.  
The introduction of the revised treatment guidelines which prescribed that HIV- 
infected individuals should be initiated on ART at a CD4 count of 500 and less has an 
impact on the attainment of this (NDOH 2015). This directly promotes the strategy of 
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using ‘treatment as prevention’ which espouses the notion that putting people on ART 
earlier will positively impact on the lowering of the overall number of new HIV 
infections and therefore result in fewer people needing treatment (NDOH 2013)  
With the inability of various countries to control the HIV epidemic and the increasing 
number of new HIV infections, the treatment as a preventative measure for HIV 
infections was introduced. ART has been shown to be effective in preventing the 
acquisition of HIV infection when given as a prophylaxis before or after exposure to 
HIV to prevent transmission from HIV infected persons (NDOH 2015). 
A recent shift proposed in the approach to curbing the scourge of HIV is the ‘test and 
treat’ strategy. This is the model of universal voluntary HIV testing with immediate 
commencement of ART for those diagnosed HIV positive (NDOH 2012). Furthermore, 
it is proposed as another form of using treatment as a preventative measure for HIV 
infection. The model is likely; however, to have its own challenges relating to 
adherence and needs to be explored further as a prophylactic model for HIV. 
According to Sithole (2013), the provision of ART to persons living with HIV and 
requiring treatment in South Africa has brought hope to people who otherwise would 
not have survived. In addition, it has led to improved quality of life, reduced morbidity, 
mortality and the number of deaths resulting from AIDS-related illnesses and has 
generally prolonged the lives of many people living with the virus. 
 
The UNAIDS (2012) reports that there is a noted decline in the number of AIDS-
related deaths by at least 24% since 2005 and in 2011 there were 1.7 million deaths 
reported. Despite these advantages, though, the ARV roll-out programme has had its 
fair share of challenges such as non-adherence or poor adherence to ART and the 
resultant high incidence of patients being lost to follow up or dropping out of the 
programme. Rosen and Ketlhapile (2010:98) state that although public sector 
programmes for providing ART in the Sub-Saharan region have matured 
tremendously, a high rate of patient attrition is still evident. They further note that 
while much of the attrition is due to mortality, a loss to follow up or disappearance of 
patients from treatment, with no apparent reason, is very common.  
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According to Fox and Rosen (2007) approximately 59% had disappeared from the 
system and could not be accounted for in the first year of being initiated on treatment 
(Rosen & Ketlhapile 2010:98).  The international studies such as the one conducted 
by Atav, Senir and Darling (2015) report that the knowledge of HIV and AIDS patients 
and the public in general regarding HIV and AIDS policies, such as the ART policy of 
South Africa, is still not sufficient to form a basis for change in behaviour among the 
at-risk groups and people living with HIV. According to NDOH (2015), the ART policy 
of South Africa does not address the issue of poverty among people living with HIV 
until their CD4 count is below 500, which is when the patient qualifies for a disability 
grant provided by the Social Department of South Africa. Furthermore, the policy 
indicates that people who are HIV positive and have a CD4 count of less than 500 or 
have reached stage 4 of the WHO clinical staging, qualify for a disability grant and 
should be started on ARV immediately. Obviously the protocol of initiation of ARV has 
to be followed.  
This leads to people intentionally having sex with someone who is HIV positive, or 
they stop taking the ARV drugs so that they can qualify, or so that the disability grant 
should not be stopped. For example, according to Sileo (2015:1), high-risk groups 
such as commercial sex workers, due to poverty and the need to survive will engage 
in unprotected sex in order to earn money. High-risk sexual engagement such as sex 
without using a condom yields more customers and a higher income. Change in 
behaviour is dependent on what the individual perceives as benefits as opposed to 
what the individual perceives as risks or threats (Sileo 2015:1). 
Jean, Moh and Danel (2014:4) report that patients are more inclined to change their 
sexual behaviour after the initiation of ART and prevention counseling. Wamoyi, et al. 
(2011:633) indicate that sexual desire changes over time, with many in their research 
reporting diminished desire at 3 to 6 months of taking ART as compared to 18 to 24 
months of use. Some patients reported that they feared re-infection or infecting 
others, or that engaging in sex would awaken the virus and weaken them, and that 
they might die.  
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Hoang, Ding and Groce (2015:746) researches on female African-Americans indicate 
that most respondents believe that they will pray to God, or according to their culture, 
they believe that their husbands or boyfriends are being faithful. It is evident in most 
of these studies that patients living with HIV and AIDS lack knowledge about 
antiretroviral treatment (Medley, Bachanas and Grillo 2015:286). 
2.5.  LEGAL FRAMEWORK INFORMING SOUTH AFRICAN ANTIRETROVIRAL 
TREATMENT PROGRAMME  
 
According to Sithole (2013), there are two important strategic documents informing 
the NDOH ART programme in South Africa: namely, the National Strategic Plan 
(NSP) and the National Antiretroviral Treatment Guidelines to assist with the 
implementation of the programme. These two documents are discussed briefly below. 
2.5.1.  National Strategic Plan (NSP) of 2012-2016  
 
According to NDOH (2012), the NSP reflects the progress made in achieving a 
clearer understanding of the challenges posed by these epidemics and the increasing 
unity of purpose among all the stakeholders, who are driven by a shared vision to 
attain the highest impact of policies towards long-term vision of zero new HIV and TB 
infections. NDOH (2012) indicates that ART expansion programme has resulted in an 
increase in ART facilities countrywide to about 2 552 currently and more people 
accessing treatment.  
 
The NSP focuses specifically on expanding the quality and reach of health and 
wellness and is geared to addressing the gaps identified in the previous NSP of 2007-
2011. The gaps identified include inadequate co-ordination of the public sector, 
private sector and non-government sector responses, the weak governance and co-
ordination structures of SANAC (from ward to national level), the lack of robust 
monitoring and evaluation of the NSP, the failure to ensure a truly multi-sectoral and 
integrated response, weak focus on human rights and justice, and the lack of a 
comprehensive and integrated approach to HIV and TB prevention. The NSP 
suggests that these gaps be addressed through annual HIV testing for everyone in 
South Africa, initiation of every HIV-infected individual on ART when their CD4 count 
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is 500 and less and the strengthening of adherence counseling programmes to 
ensure retention in care. 
 
2.5.2.  National Antiretroviral Treatment Guidelines 2004 and 2015  
 
According to the NDOH (2015:16), the main purpose of these guidelines is to improve 
the clinical outcomes of people living with HIV, to reduce morbidity due to TB/HIV co-
infection, to reduce HIV incidence and to avert AIDS-related deaths in the most cost-
efficient manner by ensuring that people living with HIV start with the right therapy at 
the right time. The National Antiretroviral Guidelines also seek to ensure timely HIV 
diagnosis, management, treatment and initiation of ARVs for treatment for all eligible 
populations to achieve best health outcomes in the most cost-efficient manner. The 
NDOH (2004:52-57) focused on defining adherence and formulating strategies to 
support and improve adherence to ART, clearly defining roles and responsibilities of 
the Health Care Team. 
The NDOH (2009) indicated that the Honourable President Jacob Zuma announced 
new key interventions to improve antiretroviral treatment (ART) access to special 
groups such as HIV positive infants, pregnant women and TB and HIV co-infection. 
This announcement resulted in more than 2.6 million people being initiated on ART by 
mid-2014 (NDOH 2015:14). Furthermore, in 2013, the fixed-dose combination pill 
(FDC) was introduced, made up of the regular three drugs used in the first-line 
regimen to improve adherence and retention.  
 
In addition, in 2014,  the South African Minister of Health, Dr. Aaron Motsoaledi 
announced that the threshold for initiation of ART will rise to CD4 count ≤500 cells/μl 
and that the PMTCT programme will now adopt the B+ approach, which entitles every 
pregnant and breastfeeding woman to lifelong ART regardless of CD4 count or 
clinical staging(NDOH 2014). 
 
In the new guidelines effected by NDOH (2015), the approach focused on providing 
the patient with a comprehensive treatment plan and on-going monitoring to ensure 
adherence. In January 2015, the treatment guidelines were reviewed and a new set 
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was introduced which re-emphasized the importance of adherence and of socio– 
economic support so as to ensure positive treatment outcomes for patients and the 
identification of issues that impact on optimal adherence. There was also a shift in the 
approach used as the NSP emphasizes negotiating the treatment plan and allowing 
the person to commit to the plan. They further identified main factors that have an 
impact on adherence and these are personal and environmental factors (NDOH 
2015:17-18).  
 
Furthermore, these successes are underpinned by a range of interrelated, evidence-
guided strategic and operational plans, monitoring initiatives, and policies and 
guidelines, paving the way for South Africa to attain its objective of reducing mortality 
from HIV and TB. However, there is a need, to strengthen the focus on adolescents 
and prevent them from acquiring HIV in line with Department of Health 2020 strategy 
(Vun 2014). These new guidelines will assist in providing the necessary guidance 
towards improved management of HIV across different populations in South Africa. 
2.6.   CHALLENGES REGARDING ANTIRETROVIRAL TREATMENT 
PROGRAMME IMPLEMENTATION  
 
Despite the success of the programme, it is not free of challenges. Some of the 
identified challenges that may have an impact on adherence to ART in the long term 
are discussed below. According to Sithole (2013), the success of the ART programme 
is determined by early identification of infection in PLHIV, rapid and appropriate 
starting of ART, high levels of viral suppression as well as the management of 
toxicities.   
According to Sithole (2013), the current status of the ART programme and its 
implementation in South Africa is encouraging but significant challenges remain and 
some are discussed in the following subsections. 
2.6.1.  Linking and retention of patients to care 
 
According to WHO (2010), retention of patients to care is referred to as client’s 
continued engagement in health services and captures the whole continuum of HIV 
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care from enrolment in care to discharge or death of the client. In addition, retention in 
care to antiretroviral treatment (ART) is a critical element of HIV care and associated 
with optimal individual, public health outcomes and cost effectiveness. 
 
The challenges facing the ART programme in South Africa is the ability to initiate and 
retain people living with HIV on their treatment regimens, according to Stricker, Fox 
and Gill (2014:465). Furthermore, there is strong evidence that many patients with 
chronic illnesses such as asthma, hypertension, diabetes and those living with HIV 
have difficulty adhering to their recommended regimens.  
 
The outcome of HCT is only successful if those who are HIV –negative are supported 
to reduce their risk of acquiring HIV and also those HIV positive are successfully 
linked to the continuum of care( NDOH 2015:39).  According to Stricker, Fox and Gill 
(2014) indicated that despite the significance of retention in care, patients living with 
HIV are still find it difficult to follow the recommended behaviour by the health care 
providers. In addition, inadequate retention leads to decreased health outcomes such 
as morbidity, mortality, and drug resistances, risk of transmission, increased costs 
and lower productivity. 
 
2.6.2.  High levels of loss to follow up (LTFU) to Antiretroviral treatment 
 
According to Stricker, Fox and Gill (2014), loss to follow up (LTFU) represents clients 
who disengaged from care at any stage of the continuum of care. Despite the efforts 
of the health providers, for various reasons, there is still a significant loss of patients 
from the time that people are diagnosed with HIV to the first assessment of ART 
eligibility. According to NDOH (2015:39), the treatment cascade shows two main 
leakages: people lost between a positive HIV, CD4 test, and those lost between CD4 
test and the return visit for CD4 test result.  
 
Challenges facing people living with HIV include having to travel long distances to the 
clinic, long waiting times at the clinic, clinic staff shortages, inability to take time off 
work, lack of full understanding of the treatment plan and fear of stigma and 
discrimination.  
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However, if these patients are effectively linked to prevention, treatment and care 
services, HCT enables those being tested to make positive health –related decisions.  
According to Lalloo and Pillay (2008:132), despite these gains, the challenge of late 
presenters at the facilities continues to occur throughout the world including South 
Africa, with the resultant ongoing burden of opportunistic infections including TB. In 
addition, the pace of the implementation of the ART programme in the provinces is 
still impeded by the human resources crisis that is being experienced by the 
Department of Health. The lack of trained professionals, because of the difficulty of 
attracting, training and retaining of health care workers, remains a formidable 
challenge for the Department of Health. Without addressing the human resources 
issue, which includes poor working conditions, low salaries, unsatisfactory career 
pathing and lack of incentives, it will be difficult to increase the pace of ART 
implementation in the province (Ford 2014:24).  
2.7.  BENEFITS OF THE SOUTH AFRICAN ANTIRETROVIRAL TREATMENT 
PROGRAMME  
 
Stricker, Fox and Gill (2014:465) indicate that the scaling up of antiretroviral treatment 
in South Africa has succeeded in increasing the number of people taking ARV. By the 
end of 2007, the WHO reported that an estimated 27% of people that required 
treatment were getting it. In addition, the number of people receiving ARV was 
estimated to have increased by 56% in 2009 according to a WHO report (UNAIDS 
and WHO, 2010). The National Strategic Plan calls for treatment care and support for 
80% of HIV positive people by 2011 (UNAIDS, 2012). However, the target was not 
met due to challenges such as human resources, late initiation of ART, lost to follow-
up, establishing of a tracer system and effective use of existing resources, which will 
all need to be addressed.  
Li (2014:998) postulates that ARV drugs have revolutionized the management and 
care of HIV and AIDS patients. New results of these studies indicate that HIV and 
AIDS patients can recover to some extent from AIDS stage Ill to HIV infection.  
According to Van Zyl, Frenkel and Chung (2014:1643), ART has a number of 
benefits. Some of the benefits are that it delays the onset of AIDS and prolongs a 
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healthy life. Studies by Eaton (2014:23-34) indicate good outcomes following the use 
of ART in the public sector. Continued success, of course, will depend on patients’ 
adherence to the therapy and their attitude towards ART. The introduction of the ART 
programme in South Africa brought hope to many people living with HIV and AIDS.  
The reports quoted above provide evidence that the use of ARV drugs has saved the 
lives of thousands of people living with HIV. It has led to improved quality of life, 
reduced morbidity, mortality and number of deaths from AIDS-related illnesses and 
has generally prolonged the lives of many people living with the virus. According to 
the UNAIDS (2012), there is a noted decline in the number of AIDS related deaths by 
at least 24% since 2005. 
2.8.  ADHERENCE TO ANTIRETROVIRAL TREATMENT 
 
According to Eaton, Mezies and Stovee (2014:23-24) Antiretroviral Treatment (ART) 
requires life-long adherence to be effective, and to prevent the development of 
resistant strains. In addition, HIV is a chronic disease that eventually results in AIDS 
and death unless managed appropriately with ART. Successful ART results in 
suppression of HIV replication and halts clinical progression of the disease (Maartens 
et al. 2012:512). Non-adherence to ART is associated with incomplete viral 
suppression and the selection of drug-resistant viruses that will limit therapeutic 
options. 
 
2.8.1.  The importance of adherence 
 
Van Loggenrensberg, Gray and Gengia (2015:299) indicate that the success of 
antiretroviral therapy depends solely on the patient’s level of adherence; therefore, 
adherence, toxicity and resistance are matters of concern in this research. The lack of 
adherence and possible resistance to ART need to improve in patients taking ART in 
order to overcome the challenges of the available drugs. 
Adherence to ART is essential for the successful treatment of HIV and AIDS, as it 
results in the decrease in viral load (VL), morbidity and mortality while increasing the 
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chances of survival. It decreases the prospects of hospitalization and reduces the 
possibility of resistance to ART (Van Loggenrensberg et al. 2015:299). 
2.8.2.  The nature of adherence  
 
Adherence to ART is critical for people living with HIV and who are on ART, in order 
to maintain good health. For a patient living with HIV to successfully adhere to and 
comply with ART medication, the patient must be well motivated, knowledgeable, 
committed, and get support from the health worker and from friends and family 
according to Holtzman, Brady and Yehia (2015:445). Furthermore, adherence to ART 
must be close to 95% to achieve success. Good adherence will add between five and 
seven years to the life expectancy of people living with HIV.  
Emamzadeh-Fard, Fard and Koosha (2012:346) noted that although ART reduces the 
numbers of HIV and AIDS related deaths significantly, appropriate adherence levels 
are recommended for optimum viral suppression in the therapeutic response process 
in PLHIV. 
Studies conducted by Khalili, Rohani and Seyedalinaghi (2012) indicate that patients’ 
mean adherence rates to ART in three months follow-up assessed by self-reporting 
methods was 65.5%, while by pill count method it was 60.4%. The study was about 
adherence to antiretroviral therapy among Iranian HIV/AIDS patients. It was noted 
that participants who were living with their family members had a significant increase 
in adherence rates. This shows that an adherence level of above 95% for patients 
living with HIV is still a challenge. Sithole (2013) concludes that adherence levels of 
65% are not acceptable, because, she argues an acceptable rate would be above 
95%. There are many patients on ART who continuously fail to adhere to their 
medication and this leads to first line regimen resistance (Sithole 2013). 
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2.8.3. Challenges regarding adhering to Antiretroviral treatment 
 
The biggest challenge facing the ART programme in Sub-Saharan Africa and South 
Africa is the ability to initiate and retain people living with HIV on the treatment 
regimens (NDOH 2012). It was indicated by Rosen and Ketlhapile (2010:98) that 
although public sector programmes in the Sub-Saharan region have matured, a high 
rate of patient attrition is still evident. They further indicate that while much of the 
attrition is due to mortality, loss to follow up or disappearance of patients from 
treatment with no apparent reason is very common.  
Bucciardini, Fragolla and Abegaz (2015:136) reported that ART programmes in Africa 
only managed to retain approximately 60% - 70% of patients on therapy three years 
after initiation on therapy. Gengerg, Lee and Rodgers (2014:85) indicate that the 
study regarding the barriers to adhering to ART found that among patients living with 
HIV, many reported that they forgot the sequence of the treatment. In addition, they 
could not take the medication in front of their family members or friends because they 
did not know about their HIV status. Furthermore, some reported that the medication 
was too complex and they also lacked knowledge about the treatment.  
According to Van Boekel (2013:23), a similar study conducted in Botswana also 
reported barriers such as stigma, discrimination, migration and side effects of ART as 
key challenges to adhering to and complying with ART. In this study, the cost of ARV 
drugs was found to be a serious challenge. Van Boekel (2013: 23) indicates from a 
study that trust between health care providers and the patient is crucial for successful 
implementation of an ART programme. The study was conducted in the Connecticut 
Department of Corrections in the United States of America, and they looked into trust 
between the health care providers and prison inmates and the acceptance and 
adherence to antiretroviral medication. 
It is therefore essential that adherence should be improved by intervention designed 
to address the barriers. People living with HIV must be given accurate information for 
them to understand what it is that they as patients need to do.   
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Wasti et al. (2012) report that stigma; discrimination and the issue of privacy are 
some of the barriers to the success of ART implementation, especially regarding the 
problem of disclosure to family members and friends. HIV and AIDS patients need to 
disclose their status to one person, a member of the family or a friend, who will 
support them.   
Wasti, et al. (2012) indicated that privacy is also considered another impediment to 
treatment and adherence, because in choosing to keep their positive status a secret, 
patients might not get treatment. It is also indicated that depression and psychiatric 
conditions such as depression and stress especially among adolescents, occur as a 
result of non-adherence to the treatment. It has been noted by Wasti et al. (2012) that 
adolescent patients taking ARV are unable to cope with depression or stress and this 
causes them to miss treatments. Warner (2013:23) states that participants with 
partners, such as people in heterosexual relationships, were associated with good 
adherence, that is, taking their ARV prescription as prescribed, while support from 
friends and other family members was not as significant.  
Their findings also indicate that partners who were both HIV positive and both taking 
ARV supported each other more in taking ARV than friends and other members of 
family or relatives. A study conducted by Berg (2015) indicates that there are main 
barriers to ART success, not limited to the following: forgetfulness, the social and 
physical environment, the complexity of the regimen, side effects of the medication, 
inadequate knowledge on the part of the patient about ART, such as its benefits and 
side effects.  
However, Berg (2015) points out that these barriers may be overcome by providing 
patients with sufficient health care information in terms of the benefit of ART, 
comprehensive pre-treatment, post-treatment and on-going counseling at each visit to 
the facility (Nchendia 2012). 
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2.9.  FACTORS FOR POOR ADHERENCE 
 
According to Maartens et al. (2012:515) factors that may have either positive or a 
negative impact on an individual adherence behavior may be divided into three 
categories, namely patient related, regimen related and disease related (as cited by 
Mathebula 2014).  
The major impact on adherence lies with the individuals on therapy and their 
interactions with their families, communities and care givers. The more favorable 
these relationships, the more likely the individuals are to remain adherent over time. 
The value of an individual accepting the HIV status and being properly prepared for 
therapy should not be underestimated. Many people simply just forget to take the 
medication. The use of devices such as pill boxes, cell phones and diaries to remind 
them to take their medication can be useful in this case according to Sithole (2013). 
2.9.1. Socio-economic factors  
 
According to Kagee (2006:415), social and economic factors may combine to yield 
poor adherence outcomes in South Africa. Many people are living in poverty in South 
Africa and have limited or no financial resources to meet treatment requirements. 
These circumstances may lead to poor adherence outcomes. 
On the other hand, however, Heyer and Ogunbanjo (2006:8) state that socio-
economic factors are not consistently predictive of adherence. They assert that in 
studies carried out in India and South Africa, no association was found between 
adherence and the patient’s economic status. A number of investigators relate the 
costs of accessing treatment at the level of the individual and his or her family to poor 
adherence outcomes.  
For example, Roura et al. (2009:48) regard cost such as transport and waiting times 
as important barriers in addition to stigma, family pressures and religious beliefs. 
Hardon, Davey, Gerrits and Hodgkin (2007), in a review of studies conducted in 
Tanzania, Uganda and Botswana, conclude that although patients are highly 
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motivated to adhere to their medication as prescribed, constraints such as transport 
costs, user fees, long waiting times, hunger, stigma and discrimination, lack of social 
support, side effects and lack of appropriate counseling all undermine such intentions.  
Mukherjee et al. (2006:124) also confirm that costs such as payment for 
transportation to and from clinics serve as a deterrent to ART adherence. They further 
state that the lack of adequate food has also been associated with poor adherence to 
ART. Socio-economic factors reported to have a significant impact on adherence are 
poor socio-economic status, poverty, illiteracy, low levels of education, 
unemployment, lack of effective social support networks, unstable living conditions, 
long distance from treatment centres (Lupu 2014:75).  
Heyer and Ogunbanjo (2006:5), however, state that educational levels, literacy, 
income and housing status are not predictive of adherence. Heyer and Ogunbanjo 
(2006:5) report that poverty can influence adherence because access to the financial 
means to travel to and from the ART clinic, to pay for child-minders during a parent’s 
absence to access treatment and to attend to several, competing needs and 
responsibilities all come into play (Simoni  et al. 2009:192). For the poor and the 
unemployed, lack of financial resources to pay for the kind of food stuffs required to 
be taken alongside medication may be of particular concern (Hogerzeil 2013:680). 
According to NDOH (2010:9), poverty is one of the major contributors to poor health 
and treatment outcomes through food insecurity in as far as HIV and TB acquisition 
and treatment adherence are concerned. The SA government, in order to support 
adherence through its Social Development Department, has introduced a chronic 
disease grant assistance for those HIV infected who cannot support themselves and 
their families (NDOH  2013:114).  
The qualification criterion for the grant is that an HIV-infected person must be too sick 
to work and when their health improves the grant is terminated (SASSA 2012). From 
a study conducted in the Cape Peninsula, South Africa, with 29 patients, it was found 
that in order to keep their CD4 counts low, some manipulated the treatment so that 
their viral loads remained high (De Paoll, Mills & Gronningsaeter 2012: 6). 
Furthermore, the commonly cited reason for non-adherence is the fear of losing one’s 
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grant and that this results in some patients ‘managing‘their CD4 counts by skipping 
some doses.  
This ensures that the viral load is not completely suppressed and this enables them to 
continue receiving the grant as long as there is no improvement in the CD4 count. 
This can have devastating effects in terms of developing treatment resistance and 
treatment failure in the long run and the patient may end up with fewer treatment 
options (Sithole 2013). As far as social factors are concerned, the WHO (2006:28) 
suggests that positive attitudes of the community towards people living with HIV play 
a significant role in influencing adherence.  
The WHO (2006:28) indicates that people living with HIV and on ART and receiving 
community-based support have been reported to be less likely to be lost to follow-up. 
According to AIDS Map(2012) indicated that of the 19,668 patients studied in a 
cohort, only 6% of that receiving community-based adherence support was lost to 
follow-up compared with 9% of those not receiving any community-based adherence 
support (AIDS Map 2012). 
The findings of a study conducted by Yoder, Mkhize and Nzimande (2009:70) in five 
different sites in KwaZulu-Natal on the experience of patients on antiretroviral therapy 
suggest that challenges such as the availability of a treatment supporter, adequate 
household income and side-effects are all determinants of adherence, non-adherence 
and/or ultimate drop-out from treatment. Another important social factor, which is 
associated with adherence, is the support of significant others in a patient’s life as 
they provide support and understanding for the patient. Heyer and Ogunbanjo 
(2006:6) confirm this by stating that the presence of social support systems such as 
supportive family members, friends and treatment supporters have been consistently 
associated with good adherence to treatment. 
2.9.2. General patient-related factors 
 
Other factors identified as impacting on adherence are as follows:  
 Treatment fatigue and pill burden. According to NDOH (2010), having to take a 
number of pills as a result of co-infection with other illnesses such as TB and 
hypertension can result in fatigue and pill burden. This can result in patients 
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adhering sub-optimally to their treatment. Some patients may also develop 
‘treatment or pill fatigue’ after being on treatment for a long time and they may 
suddenly find it difficult to adhere to their recommended treatment regimens. 
Several research studies have reportedly shown adherence declining over time for 
people on long-term treatment and even with people who have been very 
successful in taking their medication (AIDSinfonet 2012). 
 Lack of disclosure, fear of stigma and discrimination (Kagee 2006:419). People 
living with HIV are often subjected to a great deal of stigma and discrimination 
which may result in their not being willing to disclose their HIV status for fear of 
being discriminated against.  
 Cultural and religious beliefs (Kagee 2006:422) play a very significant role in 
shaping and determining beliefs and values which may directly influence attitudes 
to treatment and adherence.  
 Forgetfulness and a lack of planning (NDOH 2010:18). These factors may be 
manifest when the patient attends social functions on weekends or is away from 
home and no provision has been made in terms of having adequate treatment 
available.  
 Lack of adequate financial resources and food insecurity (NDOH 2010:18) is cited 
as one of the major problems experienced in South Africa. This may result in the 
lack of money for transport to attend clinic or lack of money for food to be taken 
with the medication and this can affect adherence.  
Sithole (2013) states that the individual’s motivation, determination and an ability to 
manage his or her illness, available resources and support systems, understanding of 
possible consequences of non-adherence and expectation of positive treatment 
outcomes all interact to impact on adherence. 
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2.10. KNOWLEDGE, ATTITUDES AND EXPERIENCES REGARDING 
ANTIRETROVIRAL TREATMENT 
 
Dimatteo, Haskard-Zolnierek and Martinl (2012:74) conducted a study and looked into 
the model to improve adherence to antiretroviral treatment. The model comprises of 
the three important clinical actions:  
(1) Ensuring that patients have the right information (Knowledge) and know how to 
adhere – including listening to patients’ concerns, encouraging their participation 
and partnership in decision-making, building trust and empathy, and enhancing 
recall;  
(2) Helping patients believe in their treatment and become motivated to commit to it – 
that is, addressing the cognitive, social, cultural normative and contextual factors 
that affect patients’ beliefs, attitudes and motivation; and  
(3) Assisting patients to overcome practical barriers to treatment adherence and 
develop a workable strategy for long-term disease management – including 
assessing and enhancing patients’ social support, identifying and treating their 
depression and helping patients overcome cost-related treatment barriers. 
2.10.1. Knowledge regarding Antiretroviral treatment 
 
Seeling, Mavhunga and Thoma (2014: 268) postulate that knowledge about HIV and 
AIDS and the benefits of ART are regarded as crucial for accepting the offer to get 
tested. Therefore, efforts should be made to intensify the dissemination of HIV and 
AIDS information and to fight stigma and discrimination in society. Since cultural 
background plays an important role in the individual response to HIV-related stigma, 
counseling and health education of patients should be adapted to cultural 
characteristics.  Kaposhi , Mqogi and Schopflocher (2015:547) conducted a study in 
the Eastern Cape and recommended that an inaccuracy of the ART programme 
should be addressed; this should include improving knowledge translation during 
training of ART programme staff, ensuring the implementation of established data 
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verification policies and procedures, rethinking the design of the programme to 
reduce the burden on health facilities and personnel, and standardizing information 
management procedures amongst the various governmental and non-governmental 
stakeholders.  
Knowledge is referred to as the facts known about the treatment, feelings or 
experiences by a person or group of people, the state of knowing, awareness, 
consciousness, or familiarity gained by experience or learning specific information 
about the subject, according to Kaposhi, Mqogi and Schopflocher (2015:547). 
A study conducted in Nigeria looked into PLHIVs knowledge about ARVs; they found 
out that HIV/AIDS knowledge was remarkably high. In addition, it was found that 
knowledge of ARV drug combinations, the appropriate time to start ARV, the benefits 
of taking ARV regularly and the possible results of not adhering to one’s ARV 
medication was high among all the participants (Weiser, Tuller and Frongillo, 2010). 
According to Munthali, Mvula and Maluwa-Banda (2014:60), scores achieved by 
participants on knowledge about HIV, including the cause, mode of transmission and 
progression of the disease, were high, with an average score of 86%. In addition, the 
majority of patients were aware that taking ART could have side effects and knew that 
missing doses could lead to disease progression. 
In these studies it emerged that there was a need to reinforce educational messages 
that ART does not cure HIV and AIDS and that missing doses could cause drug 
resistance and lead to the progression of the disease. Whether or not good HIV and 
ART knowledge among these patients translates into good adherence needs further 
evaluation.  
The patients’ knowledge of ART is crucial in this study. It is the assertion of this thesis 
that if people living with HIV and AIDS were given information about the benefits and 
the side effects of ART and its impact on their wellbeing, the programme would have 
many more people on the treatment, if all systems were in place. It is also relevant to 
say that adherence would be less of a problem if people were given the relevant 
information and the support systems mentioned above were in place. 
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2.10.2. Attitudes to Antiretroviral treatment  
 
Sellam and Flower (2014:98) indicate that the concept “attitude” is defined as a stable 
predisposition, a general and enduring positive or negative feeling about some 
person, object or issue. In addition, attitudes originate from human cognition and are 
closely linked and influenced by perceptions.  
Prejudice and stigmatization refer to “a specific attitude which is a combination of 
hostile feelings, negative emotions and hostile behaviour towards others”. Beaullieu, 
Andrien and Potvin (2014:1246) define attitudes as “feelings of emotions and beliefs 
which influence the determination of behavior towards objects, persons or the 
environment”. Furthermore, people’s attitudes are made up of the cognitive - the 
knowledge and information they possess - and the affective - their feelings and 
emotions and evaluation of what is important. 
Many personal attributes, such as commitment, positive self-esteem, motivation, 
ability to deal with stress and adaptability, have been used in research to explore and 
describe HIV and AIDS-related attitudes towards people living with HIV (PLHIV), and 
ART.  Attitudes also include stigma and discrimination towards these people and 
towards ART, perceptions about ART, such as suggestions that is poisonous and not 
good for human consumption and that ART kills people. These perceptions lead to 
patients not taking the medication correctly, which ultimately leads to their resistance 
to the treatment and possibly dying.  
2.10.3.   Experiences of people living with HIV on Antiretroviral treatment 
      
French, Greef and Watson (2015:1) postulate that knowledge gained from experience 
forms an essential aid to our understanding and activities in our everyday life. The 
experiences of PLHIV can be both negative and positive and this invariably affects 
their treatment process. 
Nsanzimana, Prabhu and McDemmott (2015:216) indicate that “experience results in 
knowledge and understanding gained either individually or as a group or society 
through day-to-day living.  
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The most immediate form of experience is personal experience, the body of 
knowledge gained individually through encountering situations and events in life”. 
Patients living with HIV and AIDS experience a significant improvement in their health 
with fewer or no opportunistic infections; most patients regain their appetite and gain 
weight and experience increased energy levels.   
Yoder et al. (2009) conducted a study that looked into the experiences of patients in 
ART programmes in KwaZulu-Natal. The results of the study indicate that many 
patients experienced financial problems which mean they encountered problems in 
obtaining appropriate food and paying for transportation to the nearest facility to 
collect their medication.  
A three-country study was conducted in Uganda, Tanzania and Botswana by Hardon 
et al. (2007), according to their study patients struggled with transport and user fees, 
long waiting times, lack of food, side effects from the medication, stigma and poor 
counseling. 
A study by Ware (2009) also found that scarcity of resources was a constant problem 
for adherence, and that patients had to beg, borrow or otherwise struggle to find 
funds for transport to obtain their monthly medication. 
2.11. THEORETICAL  FRAMEWORK ADOPTED 
 
The theoretical framework and approaches guide and help the researcher to 
formulate ideas for the research (Brink 1996:66). The theoretical framework has 
implications for any decision made in the research process (Mertens 1998:3). 
Identifying the methodologies and methods that will be used in the research and 
justifying that choice is the starting point in developing a research proposal, according 
to Crotty (1998:3). This research was conducted using the Information Motivation and 
Behaviour (IMB) model of ART adherence in this study. This approach attempts to 
offer explanations for what motivates patients to seek health promoting behaviours 
and to adhere to their treatment regimens. This model enabled the researcher to 
identify the factors that are potential barriers to treatment adherence. This model is 
discussed in detail hereunder. 
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2.11.1. INFORMATION, MOTIVATION AND BEHAVIOUR SKILLS (IMB) MODEL 
 
The information, motivation, and behaviour skills model of ART adherence was 
initially developed in response to the HIV and AIDS epidemic, in order to understand, 
explain and promote HIV risk-reduction behaviour. The model proposes that there are 
three constructs to the model, which are information, motivation and behavioural skill 
(Amico, Toro-Alfonso and Fisher 2005:661). The IMB model is increasingly being 
used in research studies that identify, evaluate and address the deficit of 
informational, motivational and behavioural skills among ART patients that are not 
fully adhering to their treatment. The IMB model posits that information, motivation 
and behavioural skills are primary determinants of health-related behaviour (Starace 
et al. 2006:153).  
This model holds that people infected with HIV and AIDS who are on ART and who 
are well informed, motivated and possess the behavioural skills that enable them to 
act effectively, will adhere to their ART programme (Starace et al. 2006:153).  
People living with HIV who are on ART need accurate information on particular 
regimens, the correct ART intake, optimal adherence and the side effects associated 
with the regimen. If these patients lack motivation, and the skills required for them to 
take the ART as prescribed or even sufficient confidence, they will definitely 
experience challenges with adherence (Starace et al. 2006:153). Fisher and Amico 
(2008) report that sub-optimal adherence to antiretroviral therapy (ART) may have 
serious consequences for HIV patients, and for public health in general.  
According to Mayberry and Osborn (2014), the information motivation behavioral 
skills (IMB) model of ART adherence can be used to understand the dynamics of ART 
adherence and to intervene with patients to promote optimal levels of adherence. 
Even though not much has been done to assess the applicability of the IMB model to 
adherence, it has the advantage of being well understood as it isolates adherence-
related factors from other health-seeking behavior models. This model has its own 
limitations, however. The IMB model of ART adherence does not adequately deal 
with the socio-cultural and structural adherence-related factors such as stigma 
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associated with HIV and AIDS. However, in many contexts stigma does not 
necessarily impact on adherence to ART (Starace et al. 2006:153). 
Change in behaviour also depends on the situation of the patient at a given point in 
time. In this particular study, for a patient to adhere to ART, the message must be 
positive, giving the benefits of ART and the dangers of suboptimal adherence. 
Patients are then likely to adhere to the therapy. This behaviour will develop into a 
perception which can be reinforced by change in behaviour (Amico, Toro-Alfonso and 
Fisher 2005:661). 
To this end, the IMB model of adherence is an important step in the right direction. 
Despite its limitations and focus on ART adherence, the IMB model is similar to other 
health-related behavior models, in that it places the individual at the centre of 
attention.  
Despite having the knowledge of information, the motivation and skills are necessary 
to perform the behavior. Individual factors such as experiences and support of the 
family and of community members, access to facilities and affordability can all have 
bearing on whether the patient adheres to his or her treatment. The challenge to the 
health care system is that developed health care interventions should be such that 
they take into account these factors. Efforts to promote behavioural change have 
been coupled with biological intervention for preventing the spread of HIV infection. 
Strategies aimed at this, which include raising HIV awareness, promotion of male and 
female condoms and reducing multiple partners among high-risk groups have proved 
effective among some sex-workers, however, they and their clients need to be 
motivated to use these condoms as indicated by this theory (Karim et al. 2010:340). 
2.12. SUMMARY   
The literature review on ART knowledge, attitudes and experiences among PLHIV 
and who are on ART were reviewed in this chapter. The literature provided insight in 
to the study. Studies by Seeling, Mavhunga and Thoma (2014), Kaposhi, Mqogi and 
Schopflocher (2015) and Munthli, Mvula and Maluwa-Banda (2014) confirm that 
knowledge of ART is critical in attaining optimal adherence to antiretroviral treatment. 
These studies further indicate that efforts should be made to intensify the 
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dissemination of HIV and AIDS information and to fight stigma and discrimination in 
the community. In addition, the studies further revealed that there is a need to 
reinforce educational messages such as ART does not cure HIV and AIDS and that 
missing doses could cause drug resistance and lead to progression of the disease. It 
is relevant to say that if people were given information, supported and motivated to 
change their behavior, adherence would be less of a problem. 
According to Sellam and Flower (2014), attitude is defined as a stable predisposition, 
a general and enduring positive or negative feeling about some person, object or 
issue. Beaullieu et al. (2014), indicates that personal attributes such as positive self-
esteem, motivation, commitment and ability to deal and adapt to stress have been 
used inn research to explore HIV and AIDS related attitudes towards people living 
with HIV. In addition, attitudes also include stigma and discrimination towards people 
living with HIV and AIDS and the perceptions that ART is poisonous and not for 
human consumption. These perceptions, lead to patients not taking ART correctly, 
which ultimately leads to resistance to the treatment. 
The researcher reviewed literature on experiences of people living with HIV and whoa 
are on ART. From different studies reviewed (French, Greef and Watson 2015, 
Nsanzimana, Prabhu and McDemmott 2015, Yoder 2009, Hardon 2007 and Ware 
2009), it has emerged that experiences of people results in knowledge and 
understanding gained either individually or as a group or society through day-to-day  
living. Studies reviewed in this chapter, further indicates that the most immediate form 
of experience is personal experience, the body of knowledge gained individually 
through encountering situations and events in life.  
Studies reviewed in the literature also revealed that many people living with HIV and 
who are on ART experience financial problems which mean that they are unable to 
obtain appropriate food, paying for transportation to the nearest facility to collect 
medication. Furthermore, scarcity of resources is a constant problem for people living 
with HIV and who are on ART to adhere to treatment on a monthly basis.  
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2.13.    CONCLUSION 
In this chapter, the researcher reviewed literature on HIV and AIDS in South Africa, 
HIV and AIDS in Limpopo province, South African National antiretroviral treatment 
programme, and Legal framework informing South African antiretroviral programme, 
Benefits of South African ART programme, Adherence to ART and its challenges 
were discussed.  Knowledge, attitude towards ART and experiences of ART among 
people living with HIV who are on ART were also discussed. An overview of a 
theoretical framework, the information, motivation and behavioral (IMB) skills model of 
adherence to ART has been presented in this chapter to explain the modifying factors 
that would influence the patient to change behavior and to adhere to treatment. In the 
following chapter the study population, sampling technique, data collection and 
analysis as well as ethical considerations in the study will be presented. 
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CHAPTER 3 
 
RESEARCH METHODOLOGY 
3.1. INTRODUCTION 
 
In this chapter the researcher describes the research design and methodology used 
in the study. The emphasis is on the chosen research approach for this study, 
sampling strategies, instruments developed and used to generate the data, data 
generation strategies, and access negotiation. The ethical considerations adhered to 
in the study are also considered. Issues of trustworthiness of the data, data analysis 
and inferences processes are described. 
3.2. RESEARCH DESIGN 
 
The research was conducted using the qualitative enquiry method to collect data. 
According to Gioia, Corley and Hamilton (2013:1) qualitative researchers exemplify a 
common belief that this method can provide a deeper understanding of the social 
phenomenon than would be obtained from purely quantitative data. The goal of the 
study was to evaluate the knowledge, attitudes and experiences of people living with 
HIV and on ART in the health facility. Given this goal, a qualitative method approach 
was called for.  
Perez, Holt, Gokert and Chanoi (2015:1205) also indicate that qualitative design 
explores attitudes, behavior and experiences through such methods as open-ended, 
face to face interviews and focus groups. In this study, data were collected using 
interviews conducted with the people living with HIV who are on ART.  Creswell 
(2013) postulates that qualitative research is any data gathering technique that 
generates open-ended, narrative data.  
It tends to be exploratory and descriptive in nature and designed to develop an 
understanding of individuals in their natural environment. In this study, the researcher 
interviewed participants to be able to gain an understanding of the concept being 
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studied. Qualitative design was preferred because it gave the participants an 
opportunity to talk and expand more on the topic and answer open-ended questions 
(Hurley, Cummings and Browner 2013). The aim was not to generalize, but to get the 
understanding of the issues related to knowledge, attitude and experiences of the 
participants.  
According to Calitz, Strydom and Roux (2014:153), the main goal of exploratory 
studies is to express a new area of interest to gain an understanding of a concept. In 
addition, exploratory studies lead to a greater understanding of the concept 
researched and may not necessarily provide a detailed, accurate and replicable body 
of data (Barbie 2010:117). In this study, the researcher followed an explorative 
method to achieve an understanding of a concept researched not necessarily 
accurate and replicable data as mentioned by Barbie (2010:117).    
3.3. SAMPLING STRATEGIES  
 
According to Denscombe (2014) sampling is defined as the selection of some units to 
represent the entire population from which the units were drawn. There is very little or 
no assumption that the sample will be representative of the larger population and as a 
result the findings cannot be generalized. In purposive sampling, the researcher uses 
his/her own judgments when selecting possible participants for the study. (Robinson 
2014: 25). In this study, the researcher used purposive sampling strategy to select the 
participants.  
3.3.1. Sampling strategy  
 
Sandelowski (1995:179) states that efficient sample size in a qualitative study is 
dependent on the amount, depth and richness of the data the researcher wants to 
gather. 
Following the intensity sampling strategy as described by Collins, Onwuegbuzie and 
Jiao (2006:83), the researcher purposely recruited participants attending the wellness 
clinic in the facility. The participants for the face-to-face interviews were purposefully 
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chosen as they present themselves at the wellness clinic. On a daily basis, clients 
present to a dietician consulting room for dietetic services. As they present to the 
Dietician (researcher), the researcher had an opportunity to request them to 
participate in the study. Those accepted to be part of the study were interviewed and 
five participants accepted to participate in the interviews.  
 
3.4. INSTRUMENTATION 
 
This section describes the development of the research instruments, in particular the 
development of the interview schedule for the participant’s face-to-face interviews. 
3.4.1. Development of the interview schedule for the participants 
 
The development of the research instruments was informed by reading and 
preparation done during the research proposal writing stage. The conceptual frame 
work (model) which the researcher adopted in this study was also used to develop 
questions in the interview schedule. All the questions developed were focused around 
the questions and objectives of the study. The interview schedule was also piloted 
with two participants at the study area. This helped in making sure that data collected 
is relevant, reliable and useful. The interview schedule first draft was submitted to the 
supervisor for comments. The supervisor comments were incorporated and resulted 
in a final interview schedule.  
An informed consent form was also developed and attached to the interview 
schedule. The consent form indicated the purpose of this study and observed the 
following ethical principles  
 The participant’s participation was voluntary and each participant had the right to 
withdraw at any point, for any reason, and without prejudice. 
 Only the researcher had access to the raw data and no names appeared on the 
interview schedule. 
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The interview schedule included closed and open-ended questions. The open-ended 
items were meant to allow the participants to provide more details on the problems 
faced and to make suggestions for improving the provision of ART services.  
The interview schedule consisted of six sections, demographical information, 
knowledge, attitudes, experiences, socioeconomic factors questions that relate to the 
study’s objectives.  
In particular, the following matters were covered in the interview schedule: 
SECTION A: Demographic information: The researcher wanted to establish the 
background information of the participants in terms of home language, marital status 
and any information that might be of relevance in this study. 
SECTION B: Participants knowledge questions: In this section the researcher 
sought to obtain the participants knowledge and assessed using questions developed 
in the interview schedule (Annexure B). The researcher asked questions about 
antiretroviral treatment knowledge and what do they do in the human body. The 
researcher also asked questions pertaining to whether there is any information 
regarding ART that was provided to the participants, whether they know the names of 
ARV they are taking? 
SECTION C: Participants attitudes questions: The researcher wanted to obtain 
information of the participant’s attitudes towards ART. The questions in relation to 
attitudes were developed (Annexure B), such as what are their feelings towards ART, 
whether they think that ARV help them, or whether other people are against ARV, 
why they are against ARV?, whether ARV cure HIV and AIDS, or is ARV make 
people sick?, why they did decide to start the treatment and whether they can advise 
other people to take the treatment.  
SECTION D: Participants experiences questions: In this section, the researcher 
sought to gain a better understanding of participants experiences on ART, gain an 
understanding of how life was before and after the start of ART, whether the issue of 
adherence discussed, the importance of adherence and the danger of missing doses 
and whether starting ART was easy or difficult to them. 
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SECTION E: Participants economic factors questions: The researcher wanted to 
obtain information of the participant’s economic factors that encourage or discourage 
them to take treatment. The researcher also wanted to understand whether the 
participants are earning an income, which provides the financial support and whether 
they are any economic services assisting participants in the community. 
SECTION F: Participants social factors questions:  In this section, the researcher 
wanted to gain an understanding of participant’s social factors that support them to 
take their treatment regularly. The researcher also wanted to gauge whether the 
participants have disclosed their status to anyone such as friends and family and 
whether they are members of any support group in the community. 
3.5. DATA GENERATION STRATEGIES 
 
Since a qualitative research design was used (Corbin and Straus 2014), the 
researcher followed one data generation strategy. It is discussed in greater detail 
below. Creswell (2013) reports that data collection is defined as the precise and 
systematic gathering of information relevant to the research purpose, objectives and 
questions. The researcher was totally involved and able to interact with the 
participants.   
3.5.1. Face-to-face interviews 
 
Irvine, Drew and Sainsbury (2013:87) state that an interview schedule is defined as a 
written list of questions, open or closed-ended, prepared for use by an interviewer, in 
a person to person interaction. In addition, this may be face-to-face or by use of 
telephone or any media. The researcher used face-to-face interviews as a method of 
data collection.  
The face-to-face interviews were approached as structured conversations based on 
the on a pre-arranged set of questions (Irvine, Drew and Sainsbury 2013:87-106). 
The interview sessions were scheduled over five days in the Witpoort Hospital 
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dietician private room in June 2013. All sessions interviews were tape-recorded and 
notes were taken as a back-up. 
The researcher commenced each interview by greeting his interviewees and thanking 
them for taking part in the study. Each interview took about half an hour to an hour. 
All interviews were conducted in Sepedi, but interviewees were also allowed to 
express themselves in their language of choice.    
3.6. ACCESS NEGOTIATION AND ETHICAL CONSIDERATIONS 
 
The researcher did not encounter any difficulties with accessing his units of 
observation (which were five people living with HIV who are on ART) as he had been 
working in this Hospital as a Dietician. In considering the ethical implications of the 
study, the researcher tried to remain true to the notion of this study as a critical 
examination of underlying social systems with the purpose of furthering human rights 
and social justice (Mertens 1998:135). In addition, the provision of dietetic services to 
people living with HIV was regarded as a human right and those rights are being 
upheld in the interest of social justice. It was not difficult for the researcher to conduct 
the interviews as an insider of the research site, because he followed all the relevant 
ethical considerations in conducting social research. The basic considerations when 
conducting social research involve recognizing and making ethical choices, making 
principled decisions, ensuring confidentiality and obtaining informed consent from 
participants whilst maintain research integrity (Babbie and Mouton 2001:520). The 
basic procedural considerations that guided the data generation and data analysis 
steps followed in this study are discussed below.  
3.6.1. Informed consent 
 
The researcher provided accurate information to his participants regarding the 
purpose of the study and what participation entailed. 
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3.6.2. Voluntary participation 
 
The participants in this study had the right to voluntary decide whether or not to 
participate. Participants also had the right to terminate their participation at any time 
during the study without fear of intimidation or penalties. The researcher informed all 
the participants about the purpose of the study and participants voluntarily 
participated. 
3.6.3.   Confidentiality 
 
Interviews were conducted in a private room. According to Henn, Weinstein and 
Foard (2006:85), confidentiality refers to protecting and not sharing personal 
information of the participants without their consent. In this study, the collected 
information, recordings, informed consent forms and other project materials were kept 
in a locked space at researcher’s office. The information was accessible to the 
researcher alone. The tape recorder was password protected and only available to 
researcher. The researcher is planning to dispose of the raw data five years after the 
degree has been conferred. 
3.7. TRUSTWORTHINESS OF DATA GATHERING 
 
According to Geissbuhler, Jafran and Buchan (2013:1), trustworthiness is defined as 
a term used to demonstrate rigor in qualitative research. In addition, trustworthiness is 
required in any study to prevent errors of either a constant or intermittent nature. The 
researcher wanted to uncover more and more descriptions by probing, taking notes 
and tape recording the interviews. Participants were allowed to express themselves 
openly in their own preferred language. A combined process of transcription and 
translation of the data collected from the participants was conducted. This process 
was done before the thematic analysis commenced. 
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3.8. DATA ANALYSIS  
 
The interviews data, which was collected by means of tape recorder, was transcribed. 
The theoretical framework used in the research guided the conceptualization of the 
categories and themes in the data analysis. 
3.8.1. Data analysis strategies for the study 
 
In this study, data analysis will start with listening to the tape recordings numerous 
times. The tape recorded interviews will be transcribed and translated to English. 
Similar patterns were extracted from the interview transcripts. The data were coded 
and analyzed manually. Themes were identified. In thematic analysis, the researcher 
is predominantly interested in the emergence of themes from the collected data.  
3.9. THE INFERENCE PROCESS: SYNTHESISING THE DATA 
 
In this study, data collection focused on gaining more information and meaning from 
the participant’s experiences in their own words. The reporting and interpretation of 
data analysis will be done for each theme identified in the following chapter. 
3.10. CONCLUSION 
 
In this chapter, the researcher provided an overview of the research design. A 
descriptive, explorative qualitative research design was used to explore the 
knowledge, attitudes and experiences of people living with HIV and on ART. The 
researcher used the questions developed for the interview schedule as a criterion to 
evaluate knowledge, attitudes and experiences of people living with HIV and who are 
on ART at a public health clinic in Limpopo.  
The researcher took measures to ensure trustworthiness and complied with the 
requirements for correct ethical processes and procedures. The researcher presents 
and discusses the findings in the following chapter. 
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CHAPTER 4 
PRESENTATION AND DISCUSSION OF FINDINGS 
4.1. INTRODUCTION 
 
This chapter focuses on the presentation of the findings from the research study. The 
demographic characteristics of the participants are presented. The findings of the 
study are discussed in the following sequence. 
First, the demographic characteristics of the five (5) participants are described in 
terms of age, gender, marital status, level of education, place of residences, whether 
the participants reside in urban or rural area home language, employment status and 
finally the main source of income. The demographic profile was discussed in a table 
format. 
Secondly, from the transcripts it was possible to identify main themes and these 
became the basis for the analysis of the data obtained. The identified themes were 
categorized under the following themes and sub themes: Theme 1: Experiences of 
PLHIV on ART, Sub themes: Life before starting the treatment, missing doses, 
poverty and hunger, and benefits of being on ART, Theme 2: Social Support of PLHIV 
on ART, Theme 3: Knowledge of PLHV about ART, Theme 4: Attitudes of PLHIV on 
ART, Theme 5: Unemployment and economic support for PLHIV.  Each identified 
theme and sub-theme is briefly introduced, followed by direct quotations from the 
participants that provide the support and clarity on the identified themes and the 
participant’s knowledge, attitude and their experiences towards ART. 
4.2. BACKGROUND CHARACTERISTICS OF THE PARTICIPANTS 
 
The demographic data on the sample of patients living with HIV and on ART is 
presented in terms of gender, age, marital status, current place of residence, 
residence by area whether rural or urban, level of education, home language, 
employment status and main source of income. Table 4.1 (below) shows the 
distribution of the participants by age. From this information it is clear that the largest 
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proportion of respondents falls within the age category of 30 to 39 years of age, 
namely 60%. Those 40 years and older account for 20% of the sample and those 
younger than 30 years comprise 20% of the sample.  
According to Harter (2002), life stages are characterized by a need to form 
meaningful relationships, start families and develop careers as personal 
developmental milestones. It is, therefore, anticipated that most of the people in this 
category would be concerned about their health and well-being as it has a bearing on 
their ability to form meaningful relationships, start a family and be able to develop and 
keep a fulfilling career. 
Table 4.1.  Age of the participants (N=5) 
AGE RANGES FREQUENCY PERCENTAGE (%) 
Younger than 30 years 1 20 
30-39 years 3 60 
40 years and older 1 20 
Total 5 100 
Table 4.2 (below) shows that of the five (100%) participants, four (80%) were females 
and one (20%) was male. This is consistent with the normal trends in terms of gender 
distribution of people that are living with the virus and also the general population 
where there tend to be more females than males (Stats SA 2011). It is, however, 
important to take into cognizance that this study sample is very small and cannot be 
generalized to a wider population. 
Table 4.2. Gender of the participants (N=5) 
GENDER FREQUENCY PERCENTAGE 
MALE 1 20 
FEMALE 4 80 
TOTAL 5 100 
Table 4.2 indicates that three (60%) of the participants were single whilst no one was 
married, one (20%) divorced and one (20%) separated. The fact that none of the 
participants is married might be an indicative of fear of discrimination. The two 
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participants who divorced and separated respectively indicated that they felt cheated 
and decided to move out of the relationship.  
Table 4.3. Marital status of the participants (N=5) 
MARITAL STATUS FREQUENCY PERCENTAGE (%) 
Single 3 60 
Married 0 0 
Divorced 1 20 
Separated 1 20 
Widowed 0 0 
Total 5 100 
Table 4.4 (below), depicts the level of education amongst the study participants. It 
shows that four (80%) of the participants had at least a secondary school level of 
education whilst one (20%) had primary school education only. The fact that the 
majority of participants had a secondary level of education might be indicative of the 
participants’ ability to know their treatment well, understand and recognize its 
importance and the possible consequences in the long run of not adhering to 
treatment. There has, however, not been any correlation between illiteracy and non-
adherence in terms of literature on adherence and in fact the contrary has been 
established (Heyer  and Ogunbanjo 2006: 5-9). 
Table 4.4. Educational level of the participants (N=5) 
EDUCATIONAL LEVEL FREQUENCY PERCENTAGE 
PRIMARY 1 20 
SECONDARY 4 80 
TOTAL 5 100 
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The Table 4.5 below indicates that the participants’ places of residence were 
distributed throughout the two villages which fall within the catchment area of the 
public health clinic. 
Table 4.5. Place of residence of the participants (N=5) 
PLACE OF RECIDENCE FREQUENCY PERCENTAGE 
THABO MBEKI 4 80 
LIBU 1 20 
TOTAL 5 100 
Table 4.6 (below) on the other hand, depicts that the all the participants (100%) 
resided in a predominantly rural area which is close to the hospital. The study area is 
predominantly rural and this profile is indicative of that fact. 
Table 4.6. Place of residence whether urban or rural area (N=5) 
PLACE OF RESIDENCE FREQUENCY PERCENTAGE (%) 
Rural 5 100 
Urban 0 0 
Total 5 100 
Table 4.7 (below) shows that four (80%) participants’ home language is Sepedi, while 
one of them (20%) is Zulu–speaking. It is an indication that the area is dominated by 
Sepedi speaking people. That is why the researcher made sure that the interviews 
were conducted in Sepedi and the one participant who speaks Zulu, could speak and 
understand Sepedi very well. 
Table 4.7. Participants home language (N=5) 
HOME LANGUAGE FREQUENCY PERCENTAGE (%) 
Sepedi 4 80 
Zulu 1 20 
Tshwana 0 0 
Total 5 100 
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Table 4.8 below shows that three (60%) of the participants were employed whilst two 
(40%) were unemployed. Of the three participants who were employed at the time, 
the data reveal that they were working piece-jobs at the farms around the areas. The 
two who were unemployed had been medically boarded and were no longer 
employed.  
Table 4.8: Employment status of the participants (N=5) 
EMPLOYMENT STATUS FREQUENCY PERCENTAGE 
EMPLOYED 2 40 
NOT EMPLOYED 3 60 
TOTAL 5 100 
The findings of this section of the study showed that the main source of income for 
the participants was a salary in line with the number of people employed and this was 
shown to be three (60%) as displayed in Table 4.9 (below). It also revealed that one 
(20%) of the participants was medically boarded and on pension.  
The other participant (20%) was having absolutely no source of income. This is very 
likely to have an impact on adherence to their treatment in terms of regular 
attendance at the clinic, ensuring that they have adequate food to take with treatment 
and money to cover transport and other related costs. 
Table 4.9.  Main source of income of the participants (N=5) 
MAIN SOURCE OF INCOME FREQUENCY PERCENTAGE (%) 
Salary 3 60 
Pension after medically boarded 1 20 
No income 1 20 
Total 5 100 
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4.3. RESULTS OF THE FACE TO FACE INTERVIEWS 
 
The researcher adopted a thematic analysis method to analyze data from the 
interviews. From the transcripts it was possible to identify main themes and these 
became the basis for the analysis of the data obtained.  
4.3.1. IDENTIFIED MAIN THEMES OF THE INTERVIEWS 
 
Table 4.6 depicts the main themes that emerged from the interviews and these 
themes outline the information provided during the interviews. Each participant is 
identified by a code, like for example “participant 3”. The important concerns 
expressed by the participants are highlighted in the analysis. In practice the themes 
are strongly linked to each other and as such, some repetition of key points was 
unavoidable. 
  
51 
 
Table 4.10. Themes emerged from the interviews 
 
Identified Theme 
 
Findings  from participants  
Theme 1:  
Experiences of PLHIV on ART 
Life before you start the 
treatment (ART) 
“I was always sick. I consulted many doctors and could 
not get the cause of my sickness. Doctors could not 
even tell me to check blood. One lady requested me to 
come to hospital to test, I came and tested and found 
out that I am positive. I used to take heart treatment 
and was difficult before I took treatment” (Participant 2) 
“I was very sick, a lot. My CD4 was very low. I got 
treatment at the hospital. They told me that I must take 
the treatment. I was very weak. I went to the doctor 
and took a blood test and was told that I am HIV 
positive” (participant 3) 
“I saw my body becoming weak, and was in and out of 
hospital. I then ask(ed) them to test me. No, it was ok. 
People were saying maybe I was bewitched and it was 
not like that, it was AIDS. I spoke to the nurses and 
they said I must start with the treatment.”  
(Participant 4) 
I used to get sick all the time, I did not know what was 
the problem and coming to the hospital has helped me 
a lot. The treatment that made me dream somehow, 
“laughs”. Yes, I did change my behavior, used to 
drinking a lot and (I) stop(ed) drinking alcohol and 
other (things)” (Participant 5) 
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Missing doses of PLHIV on ART “I started getting lazy going to hospital for treatment. 
One of the ladies who were attending the clinic came 
to see me, because she was not seeing me at the 
hospital. She requested me to go to hospital to take 
treatment. She told the care-givers to come and talk to 
me to go to hospital. My body was weak and was doing 
nothing at home” (Participant 1) 
 
“You know, we are males, sometimes you go far to 
work there, and people that you work with and (the) 
employer does not understand your disease, but you 
try to explain to them, but they don’t understand. I 
ended up missing my treatment. I stopped treatment 
not more than 2 months (ago).” (Participant 5) 
”No, I want to live and I don’t want to die now”. 
(Participant 2) 
Poverty and Hunger of PLHIV 
on ART 
“Many people are weak and don’t have power to work. 
I think giving them (a) grant or food will be ok. Many 
people struggle because of not having food.” 
(Participant 1) 
 
She said with a sigh: “... I have a problem of getting 
food, this treatment makes you to eat a lot and I don’t 
earn much...” (Participant 4) 
Benefits of being on ARV 
treatment  
“So I got used to treatment and things got better and I 
was right [healthy], my weight improved because I lost 
weight from 45 kg, it improved to 66 kg. So this year I 
able to go back to work.” (participant 3) 
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Theme 2:  
Social support for PLHIV on 
ART 
“The only person who knows is my daughter who will 
disclose to my parents when my last days come, 
because she’s my blood she’s with me through all 
hardships.” (Participant 2) 
“I think home is an important support system, people 
who are close to you, someone, or all, need to know at 
home so that they remind you.” (Participant 1) 
 
“There are a lot of support groups here. We attend 
Thursdays and Fridays. My family supports me a lot. I 
try to assist other people. Other people believe when 
you talk about yourself, your experiences, and what 
you have gone through. [...] I told my mother, I told my 
brother, they all support me…” (Participant 3) 
 
 
 
Theme 3:  
Knowledge of PLHIV on ART 
“They assist immune system to go up and if you cannot 
eat well, you start eating and gaining weight. They give 
you tablets to eat well, if you vomit, not to vomit.” 
(Participant 3) 
If you don’t drink on time and always, the disease will 
come back and grow.” (Participant 2) 
Theme 4:  
Attitudes of PLHIV towards 
ART 
“I was unable to walk when I came here, and my CD4 
were 120, now my CD4 is 300, I could not work.” 
(Participant 2) 
 
“My concern is that, when are we going to get healed? 
When is the tablet for healing going to come?” she 
asked. “I am ok at the moment, I can work for myself, 
and the treatment is ok.” (Participant 3) 
 
“I am concerned about what food to eat? And 
sometimes there is no money to buy food. Treatment is 
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ok; it is helping me a lot.” (Participant 4) 
 
 “I used to get sick a lot and (have) no money. I needed 
money to buy food when taking treatment and taking 
care of my kids.” (Participant 1) 
Theme 5:  
Unemployment and economic 
support of PLHIV on ART 
“Many people are weak and don’t have power to work, 
I think giving them a grant or food will be ok. Many 
people struggle because of not having food to 
eat.”(Participant 2) 
 
“(I) Think the government should give us (a) grant for 
the disease.” (Participant 3) 
 
“About the grant, we must be assisted. It is difficult if 
the tablets are finished and you don’t have money for 
transport to the hospital.” (Participant 5) 
 
4.3.2. Theme 1: Experiences of PLHIV on Antiretroviral treatment 
 
This section (and the subsequent ones) reports on the identified themes that were 
generated from the interviews transcribed with all the participants. However, some of 
the statements may appear in more than one theme where they reflect different 
meaning and experiences. 
4.3.2.1: Life before you start the treatment  
 
This sub-theme describes the experiences, as shared by the participants, before 
finding out their HIV positive status, how long after they discovered their status they 
started the treatment and what it was like living with an HIV infection and on 
treatment. Furthermore, the participants shared their experiences in relation to issues 
of adherence to ART. Participants highlighted that before knowing their HIV positive 
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status they were suffering from multiple illnesses, they were always in and out of 
hospital due to illness. They had repeated bouts of sickness.  
“I started getting lazy going to hospital for treatment. One of the ladies who were 
attending the clinic came to see me, because she was not seeing me at the hospital. 
She requested me to go to hospital to take treatment. She told the care-givers to 
come and talk to me to go to hospital. My body was weak and was doing nothing at 
home.” (Participant 1) 
“I saw my body becoming weak, and was in an out of the hospital. I then ask(Ed) 
them to test me. No, it was ok. People were saying maybe I was bewitched and it was 
not like that, it was AIDS. I spoke to the nurses and they said I must start with the 
treatment.” (Participant 4) 
Almost all participants indicated that the issue of adherence were discussed when 
they start the treatment. These are their responses: 
 
“Yes, they told me about that. If you don’t drink on time and always, the disease will 
come back and grow. They told me that if you leave a space, the disease will come 
back and grow.” (Participant 2). 
 
“Yes, they did. If they tell you to come on the date they give you, you must come on 
that date, like today is on the 20th, and next appointment will be on the 18th of next 
month, so I will come back so that I must not miss any dose.” (Participant 3) 
 
 “Yes, the sister here at the hospital told us to take the treatment on time, if you take it 
at 7 o’clock; you must always take it at the same time.” (Participant 4) 
 
“Yes, they told me that if you miss treatment, you will die.” (Participant 5) 
 
NDOH (2010) indicates that ART is a life-long treatment and requires adherence to 
be effective, and to prevent the development of resistant strains. According to Sithole 
(2013), it is indicated that an individual’s motivation, determination and the ability to 
manage his or her illness, available resources and support systems, understanding 
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the possible consequences of non-adherence and expectation of positive treatment 
outcomes all interact to impact on adherence. 
According to the NDOH (2015:36) education on adherence to treatment starts at the 
beginning of the treatment cascade, when a patient is diagnosed as HIV-positive. 
Furthermore, adherence includes taking treatment as prescribed, keeping to 
appointments for test results, referrals and further investigation.  
 
The patients’ motivation to continue engaging with care regardless of eligibility for 
ART is influenced by their experience with the healthcare system and the attitude of 
healthcare providers. 
4.3.2.2. Missing doses of PLHIV on Antiretroviral treatment 
 
Of the five participants, two participants indicated that they have missed treatment 
before. The findings are shown below:  
 
“Yes, in 2011, I started getting lazy going to the hospital for treatment. One of the 
ladies who were attending the clinic came to see me, because she was not seeing me 
at the hospital. She asked me to come to the hospital to take the treatment. My body 
was weak and was doing nothing at home.” (Participant 1) 
 
“Yes, I did miss the treatment, you know , we are males, sometimes you go far 
because you are working there, and people that you are working with don’t 
understand your disease, you try to explain to them, but I ended up missing my 
treatment. I was not well; it was not the same when I start treatment, like I was feeling 
weak, as if I will fall. I stopped treatment for two months and went back to clinic to 
collect the treatment.” (Participant 5). 
 
However, the other three participants indicated that they never missed any treatment. 
But they had difficulties taking the morning doses. 
 
 “No, I want to live and I don’t want to die now. When I started the treatment, the one 
that I used to take during the day, I used to have hallucinations but now I am well.” 
(Participant 2) 
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“I have never missed any treatment, it is the law, and I am not supposed to miss any 
dose. The one during the night is difficult, if you take it, you feel dizzy but the next 
day, and I will come to the clinic and tell them about it.” (Participant 3). 
 
“No, I never missed taking treatment. The dose in the morning is difficult because I 
get tired taking them. I cannot miss a treatment, I saw a lady that was taking ART with 
her, she stopped taking treatment for 3 months, and when she came back to clinic, 
she was using (a) wheelchair; she started drinking alcohol and not taking treatment. I 
told myself that I will not miss treatment.” (Participant 4) 
 
According NDOH (2012) indicates that across many medical conditions 50% or more 
of all patients stop taking their prescribed long term medication within the first year of 
initiation. Sithole (2013) indicates that this could be due to a number of reasons 
including the fact that patients have to submit to treatment for the rest of their lives, 
the number of tablets taken daily and co-infection with other chronic illnesses. In this 
study, two (40%) of the participants stopped or missed the treatment which correlates 
with the above statement. 
4.3.2.3. Poverty and hunger of PLHIV on Antiretroviral treatment 
 
The participants indicated several factors that complicate adherence to treatment, 
sometimes leading to non‐adherence for a period, but often just making adherence 
more difficult. Lack of employers’ and colleagues’ support and lack of education about 
the HIV/AIDS was reported by participants during the interviews (Participant 5).  
Participant 1 reported feeling lazy and staying at home for more than a month without 
going to the hospital to collect her medication. 
 
Many people are weak and don’t have power to work, I think giving them (a) grant or 
food will be ok. Many people struggle because of not having food.” 
(Participant 1) 
 
“... I have a problem of getting food, this treatment makes you to eat a lot and I don’t 
earn much...” (Participant 4) 
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According to Sithole (2013), patients on ART indicated that food complicates 
adherence and can also be a cause of non‐adherence. Furthermore, in a number of 
cases treatment with ARVs made people hungrier, but they could not afford the cost 
of additional food. Witpoort Hospital provides nutritional food (food supplements), 
such as fortified high protein supplements and other nutritional supplements 
recommended by dieticians. Mukherjee et al. (2006:124) state that lack of adequate 
food has also been associated with poor adherence to ART. This is in correlation with 
the responses of the participants interviewed in this study. 
 
According to Simoni et al. (2009,192) and Kagee (2006:416) poverty can influence 
adherence because access to financial means to travel to and from the ART clinic, to 
pay for child minders during parents absence to access treatment and to attend to 
several, competing needs and responsibilities all come into play. For the poor and 
unemployed, lack of financial resources to pay for the kind of food stuffs required to 
be taken alongside medication may be of concern. According to the NDOH (2010:9) 
poverty is one of the major contributors to poor health and treatment outcomes 
through food insecurity in as far as HIV and TB acquisition and treatment adherence 
are concerned. In this study, the findings show that three (60%) participants were 
employed temporarily and the other two (40%) were unemployed and dependent on 
the grant provided by the South African government. 
 
4.3.2.4. Benefits of being on Antiretroviral treatment 
 
This sub-theme highlights the participants’ experiences about the outcomes of being 
on ART. Almost all interviewees shared positive outcomes and experiences while 
taking ART, including an improvement in physical, social and emotional well-being, as 
well as a greater sense of optimism about the present and the future. Although some 
participants raised concerns about the possible long-term side effects of medication 
that could counteract the positive outcomes, many participants mentioned that being 
able to continue to care for their families and children was an enormously beneficial 
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outcome of being on ARVs, and interviewees praised ART for the positive results they 
noticed in their health (including weight gain and the return of physical strength). 
“I was unable to walk when I came here, and my CD4 were 120, now my CD4 is more 
than 300. I could not work. They boost the immune system of the body.” (Participant 
2) 
 
“I noticed the difference, started to gain weight and recovered from weakness and 
became normal again. Even people who knew me when I was sick noticed the 
difference.” (Participant 3) 
 
 “I feel very well, I’m light, able to work, before my whole body was sore…I’m well, I 
highly recommend these pills.” (Participant 4) 
“I was told that I have to take treatment, I was weak and lost weight. Now, I am well 
and have gained weight and working and my skin is beautiful now.” (Participant 5) 
The findings in this study show that the provision of ART to people living with HIV and 
requiring treatment in South Africa has brought hope to people who would not have 
survived. It has led to improved quality of life, reduced morbidity, mortality and the 
number of deaths resulting from AIDS-related illnesses and has generally prolonged 
the lives of many people living with the virus. This correlates with the findings of all 
participants interviewed in this study. According to the UNAIDS (2012), there is a 
significant decline in the number of AIDS-related deaths by at least 24% since 2005 
and in 2011 there were 1.7 million deaths reported. Li (2014:998-1010) postulates 
that ARVs have revolutionized the management and care of HIV and AIDS patients. 
In addition, new results of these studies indicate that HIV and AIDS patients can 
recover to some extent from AIDS stage III to HIV infection. 
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4.3.3. Theme 2: Social support for PLHIV on Antiretroviral treatment 
 
This theme describes the support structures available for PLHIV on ART and the 
importance of having these when coping with the demands of the ART programme. 
Participants mentioned a variety of support needs, including: emotional support, food, 
family support, and support from health professionals.  
In this study, it was found out that families were placed at the forefront of social, 
emotional, physical and economic support for ART and care. Relatives are often 
sources of information and encouragement on advising other members to go for HIV 
testing, including where to go and where to access support for HIV related care and 
ARVs.  
 
“My mother and my children know about my status and support me a lot. My 
neighbours know as well. The support group was there, where even the social 
workers used to come and talk to us but now is no longer there.” (Participant 1).  
 
“I think the home is an important support system, people who are close to you need to 
disclose to make it easy, even if you forget the pills someone at home will remind you 
by asking if you’ve taken your pills.” (Participant 2) 
 
“I knew my status in 2005 and my health status was not good, my sister kept on 
saying I must take ARVs…I asked my sister to come and sleep with me…she kept on 
reminding me not to forget and I told her I’ll never forget.” (Participant 3)  
 
 “I have no problems; my daughter supports me and my parents are a warm, my 
children make sure I take pills at the correct time, they ask me if I’ve taken pills, they 
even pack for me the ones I take when I’m at work… my daughter is with me through 
all hardships.” (Participant 4). 
  
According to the NDOH (2011), community health workers (CHWs) are significant 
people in providing support for PLHIV. Their roles include home visiting for further 
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support regarding adherence to treatment (including treatment for opportunistic 
infections), assisting with the various difficulties of disclosure and making 
arrangements for food parcels if necessary. 
  
“There are CHWs who do home visits so she was referred to come to my house.  I 
was able to visit the clinic again.  She motivated me because I wanted to desert 
taking treatment but she encouraged me to continue with my treatment.” (Participant 
1)  
 
Almost all participants highlighted the support they got from the nurses and doctors 
who were rendering treatment, care and support in the ART programme.  
 
“Yes, sometimes I used to not sleep at night. I went to the clinic and talk to (the) 
nurses and they told me to continue taking the treatment. They are doing a wonderful 
job and I am happy with them.” (Participant 2) 
 
“I do talk to them if I have a problem and I am happy with them.” (Participant 3) 
 
“Yes, I do, and they are doing ok and I am happy with them. If you have a problem, 
the sisters have love, they don’t talk bad about us, they are nice to us.” (Participant 4) 
 
“Yes, I talk to them, they assist me a lot. I call them teachers.” (Participant 5) 
 
This theme is an important factor in supporting adherence, and it was mentioned by 
most of the participants. However, ARV patients are usually shocked when they first 
realize they have contracted HIV, and often find it difficult to disclose to family 
members and community support groups and so do not receive the social support 
they deserve and it is shown by their responses below. 
“I did not want people to see me taking treatment. I used to take my treatment in town 
because of that. I am free now because we are many here who are taking treatment.” 
(Participant 2)  
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In contrast, other participants indicated that they have a support group and used to 
attend on Thursdays and Fridays. 
 
“There are a lot of support groups here. We attend Thursdays and Fridays. My family 
supports me a lot. I try to assist other people. Other people believe when you talk 
about yourself, your experiences, and what you have went through. I told my mother, 
I told my brother, they all support me ...” (Participant 3) 
 
People affected by and infected with HIV are often subjected to discrimination and 
rejection by their friends, family, sexual partners and work colleagues (Evian 2011).  
Even though they may be motivated to adhere to their ART for personal reasons, lack 
of or poor support from their loved ones, or feelings of being discriminated against or 
stigmatised as a result of being HIV positive may negatively impact on adherence. In 
this study, the findings are that all five participants reported that they have disclosed 
to family members especially the sister and the children. This is what they had to say:  
 
“Yes, I have disclosed to my daughter who was born in 1993. I also told my sister. 
She accepted and did not have a problem.” (Participant 2)  
 
“Yes, I did disclose to my sister, then my children. My sister did not have any problem 
and she said I must just take treatment.” (Participant 3). 
 
“Yes, I spoke to my brother and my father. My father was not happy but he took me to 
town and we talk about it. After that he was ok with that.” (Participant 4). 
“Yes, I told my mother and my sisters. They told me is part of life. I don’t have to think 
otherwise and they told me you will live like others.” (Participant 5). 
 
It is evident from this study that almost all the participants interviewed, reported that 
they received some social support from families and some engaged in community 
groups activities. WHO (2006:28) suggests that positive attitudes of the community 
towards people living with HIV play a significant role in influencing adherence. Adults 
on ART and receiving community based support.  
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According to AIDS Map (2012), it was found out that of the 19,668 patients only 6% of 
those receiving community based adherence support were lost to follow up as 
compared to 9% of those not receiving community-based adherence supports. Heyer 
and Ogunbanjo (2006:6-7) state that the presence of social support systems such 
supportive family members, friends and treatment supporters have been consistently 
associated with good adherence to treatment. In this study, the findings correlate with 
the statements given and shown in the responses above of all the participants 
interviewed. 
 
4.3.4. Theme 3: Knowledge of PLHIV about Antiretroviral treatment 
 
This theme describes the knowledge that the participants have regarding ARVs. The 
participants were asked questions such as whether they know about ARVs, their 
names, whether they know what ARVs do to the human body and any information 
provided regarding ARV. Almost all participants seem to have knowledge of 
antiretroviral treatment they are taking, even though none of them were able to call 
ARVs by their correct names. 
“I know that the medication decreases the strength of the virus and rendered it weak. 
Also assist the body not to get diarrhea.” (Participant 1) 
“I was told that I must drink it on time at nine in the morning and nine in the evening. I 
am not allowed to miss treatment; they told us that if I miss treatment, the disease will 
come back.” (Participant 2) 
“They assist the immune system to go up and if you cannot eat well, you start eating 
and gaining weight. They give you tablets to eat well, if you vomit, not to vomit.” 
(Participant 3) 
“The treatment should get completed every month. You must drink the medication at 
the right time; you don’t have to miss the treatment.” (Participant 4) 
“Yes, I know them. I wrote their names somewhere. They make me dream somehow, 
sometimes I am dizzy.” (Participant 5)  
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According to Seeling, Mavhunga and Thoma (2014:268), knowledge about HIV and 
AIDS and the benefits of ART is regarded as crucial for accepting the offer to get 
tested. Furthermore, their study that looked into knowledge of the PLHIV, it was found 
out that knowledge was remarkable high. In addition, the knowledge of ART drug 
combinations, appropriate time to start ART, the benefits of taking ART regularly and 
possible results of not adhering to one’s ART was high among all the participants. In 
this study, the participants’ knowledge is also high and it correlates with the 
participants responses mentioned above. Participants were able to know the benefits 
of ART, appropriate time of taking ART and the issue of adherence was known. The 
patients’ knowledge of ART is crucial in this study. It is the assertion of this thesis that 
if PLHIV were given information about the benefits and the side effects of ART and its 
impact on their wellbeing, the issues of adherence and loss to follow-up would be 
minimized and more people would be tested and if positive start the treatment. 
4.3.5. Theme 4: Attitudes of PLHIV towards Antiretroviral treatment 
 
This theme describes what the feelings regarding the treatment are, whether the 
treatment they are getting is helpful, whether the ARVs make the patients sick, why 
they started the treatment and whether they can advise other people to take the 
treatment.  
All participants were positive about taking ART. The positive attitudes reported came 
from the participants’ experiences since they started treatment. 
 
“I used to get ill a lot and no money. I needed money to buy food when taking the 
treatment and also taking care of my kids. Many people are weak and don’t have 
power to work, giving them a grant or food will be ok.” (Participant 1) 
 
“As for me, I want the government to help us, since I am HIV positive, I don’t have a 
house of myself, and I want the government to build the house for me. If I die, I want 
my children to have a place to stay. As for other people, I think the government must 
help people with money. Other people cannot get a job like me. Giving them money 
or a grant will help.” (Participant 2) 
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A major concern for almost all the respondents was that of prolonging life and all 
referred to it as a significant benefit of ART. 
 
“I was unable to walk when I came here, and my CD4 were 120, now my CD4 is 300, 
I could not work.” (Participant 2) 
 
“My concern is, “when am I going to get healed?” When the tablet for healing is going 
to come? I am ok at the moment, I can work for myself and the treatment is ok.” 
(Participant 3) 
“I am concern about what food to eat? And sometimes there is no money to buy food. 
Treatment is ok; it is helping me a lot.” (Participant 4) 
 
“I used to get sick a lot and no money. I needed money to buy food when taking 
treatment and taking care of my kids.” (Participant 1). 
 
Almost all participants indicated that they can advise other people to take treatment. 
The findings are indicated below: 
 
“Yes, I saw it by myself, taking treatment has helped me to live, gave strength and I 
am able to work at home now.” (Participant 1) 
 
“Yes, I can advise them to take treatment. At the moment I do tell them to go to 
hospital or clinic to test. I am not ashamed of my condition; I can tell anyone that I am 
HIV positive.” (Participant 2) 
 
“Yes, if the person can come to me, I can see the person who is sick with HIV. I can 
talk to that person to go to clinic to test.” (Participant 3) 
 
“Yes, HIV, I know HIV, if someone does not want to test and I see that person, I can 
talk to him that I am also HIV positive and tell him to go to Hospital for testing, even if 
he does not ask for help.” (Participant 5)  
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Sellam (2014:98) indicates that prejudice and stigmatization refers to a specific 
attitude which is a combination of hostile feelings, negative emotions and hostile 
behavior towards others. 
Many personal attributes such as commitment, positive self-esteem, motivation and 
ability to deal stress and adaptability have been indicated by the participants in this 
study. Almost all participants were motivated to live and continue taking their 
treatment as required.  
 
4.3.6. Theme 5: Unemployment and economic support of PLHIV on 
Antiretroviral treatment 
 
This theme describes the unemployment and economic factors that support the 
participants. Questions such as whether they are earning an income and whether 
there are any existing economic services helpful for PLHIV were asked, to understand 
the participants economic support factors. Furthermore, unemployment plays an 
important role in whether patients are able to adhere to their treatment regimens or 
not. It relates to factors such as transport and food costs that patients incur when they 
attend clinic in order to take their medication well (NDOH 2010).  
 
Two of the five participants interviewed were unemployed and the other three 
participants were employed temporary, working piece jobs as they call it.  
None of the women interviewed were in a relationship due to issues of lack of trust. 
Financial difficulties were reported almost by all participants. Their responses are 
indicated below: 
 
“Many people are weak and don’t have power to work, I think giving them a grant or 
food will be ok. Many people struggle because of not having food to eat.” (Participant 
1) 
“I think the government should give us a grant for the disease.” (Participant 3) 
 
“About the grant, we must be assisted. It is difficult if the tablets are finished and you 
don’t have money for transport to the hospital.” (Participant 5) 
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According to Yoder et al. (2009), many patients experienced financial problems which 
meant they encountered problems in obtaining appropriate food and paying for 
transportation to the nearest facility to collect their medication.  
 
Hardon et al. (2007) indicated that patients struggled with transport and user fees, 
long waiting times, lack of food, side effects from medication and stigma. The findings 
in this study show that three (60%) were employed, even though in ‘piece jobs’ and 
two (40%) were unemployed and dependent on the social grant. All participants 
interviewed struggled financially. A study by Ware (2009) also found that scarcity of 
resources was a constant problem for adherence and patients had to beg, borrow or 
otherwise struggle to fund for transport to obtain their monthly medication.  
 
4.4. SYNTHESIS OF THE STUDY 
 
The objective of the study was to gain understanding of the participants’ experiences, 
knowledge and attitudes in their own words. The information was sought through the 
use of interviews conducted with five participants. The issues reported by the 
participants affecting adherence as their lived experiences were unemployment and 
economic support, lack of knowledge of the employers and colleagues and also 
laziness of some of the participants. 
 
Factors reported by participants as promoting and supporting adherence are: being 
able to live better and able to see their children grow, support from their families and 
friends and a good quality of life. The information, motivation and behavior (IMB) 
model of adherence emphasizes that for adherence to happen one has to receive 
relevant information, getting motivated by the outcome and change behavior. There is 
always a benefit for changing one’s behavior about the consequences of one’s action. 
The respondents reported that they were given relevant information about the 
benefits of ART and about the danger of not taking the medication correctly as 
recommended. They were taught that the treatment would enable them to continue 
having a good quality of life, give them the opportunity to support their families.  
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4.5. CONCLUSION 
 
In this chapter, the participants’ background information was presented. Their 
experiences were divided into five themes and were defined and described. The 
following chapter will discuss the results, recommendations to other researchers for 
further research and to the authorities for implementation. It will also make 
conclusions of the research.  
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CHAPTER 5 
DISCUSSION, CONCLUSSIONS AND RECOMMENDATIONS 
5.1. INTRODUCTION 
 
The previous chapter presented all the data and findings of the study. In this chapter 
the researcher discusses a summary of the findings, conclusions and 
recommendations for both health authorities and for further research opportunities. 
These are discussed in relation to the objectives of the study as set out at the 
beginning. The researcher also outlines the identified strength and weaknesses of the 
study. 
5.2. SUMMARY OF FINDINGS ACCORDING TO THE OBJECTIVES 
 
The main aims of the study were to investigate knowledge, attitudes and experiences 
of people living with HIV who are on ART at a public health clinic in Limpopo. 
5.2.1. OBJECTIVE 1: KNOWLEDGE OF PEOPLE LIVING WITH HIV TOWARDS 
ANTIRETROVIRAL TREAMENT 
 
The first objective of the study was to investigate the knowledge of patients on ART 
the findings showed that the patients know ART, what it does in the human body, 
even though all five (100%) were unable to correctly pronounce the names of the 
ARVs. This is also supported by the information, motivation and behavior model 
which suggest that personal, behavioral and environmental factors largely determine 
one’s actions according to Munthli, Mvula and Maluwa-Banda (2014). Having a good 
knowledge and understanding of the benefits the patients can derive from adhering to 
ART may encourage the patients to take their treatment as required.  
All five of the participants interviewed (100%) shared positive outcomes and 
experiences while taking ART, including an improvement in physical, social and 
emotional wellbeing as well as greater optimism about the present and the future. 
This knowledge is crucial for patients to appreciate the importance of the ART and the 
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required adherence for it to work optimally and produce positive outcomes. Although 
participants raised concerns of possible side-effects of medication, all of them (100%) 
mentioned that being on ART has enabled them to continue to care for their families 
and children and has been a great benefit. All indicated that they will never stop 
taking the treatment.   
5.2.2. OBJECTIVE 2:  ATTITUDES OF PEOPLE LIVING WITH HIV REGARDING 
ANTIRETROVIRAL TREATMENT 
 
All five of them (100%) reported feeling much better after taking the treatment and 
yielded better results. Participant said they trusted the nurses and felt that they were 
listened to, respected and given a chance to ask questions.  
According to Sellam and Flower (2014), attitudes originate from human cognition and 
are closely linked and influenced by perceptions. Beaullieu et al. (2014) also reports 
that people’s attitudes, change of behavior and optimal adherence depend on the 
knowledge, information, feelings and emotions they possess and this is supported by 
theoretical model used in this study, which indicates that inaccurate information plays 
an important role in negatively affecting adherence.  
According to Mayberry and Osborn (2014), the IMB model of adherence, medication 
adherence is determined by the extent to which an individual is informed about 
his/her regimen, is motivated to adhere, and possesses the necessary behavioral 
skills to adhere in a variety of situations. Furthermore, according to Fisher and Amico 
(2008), adherence information includes accurate knowledge about the regimen, 
potential side effects and drug interactions. In addition, adherence motivation is a 
function of personal and social motivation to adhere and personal motivation to 
adhere to regimen reflects an individual’s attitudes about adherence and is based on 
one’s beliefs that medication is helpful and not taking medication as prescribed would 
have undesirable consequences. 
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However, having the accurate knowledge or information about the treatment, the 
motivation and skills necessary to change the behaviour, is not a green light to 
optimal adherence but there are still factors such as disclosure of the status, the 
beliefs, experiences and the family and community support system, access to the 
health facility, reliable transport system and money can have an effect on whether the 
patient adheres to his or her treatment. 
The personal attributes such as positive self-esteem, commitment, ability to deal with 
stress and motivation are important in optimal adherence. In this study, all the 
participants have benefited from ART in a variety of ways, such as enhancing quality 
of life and fulfilling family obligations. 
All participants reported that they are happy about the programme, about the staff in 
the facility and about ART. However, challenges are still there and need the ART 
programme to address them in order to strengthen adherence and treatment 
outcomes. 
5.2.3. OBJECTIVE 3:  EXPERIENCES OF PEOPLE LIVING WITH HIV TOWARDS 
ANTIRETROVIRAL TREATMENT 
 
This research has revealed a numbers of experiences of people living with HIV and 
AIDS such as good knowledge of ART, positive attitudes towards ART and some 
concerns about the ART programme. Yoder et al. (2009:70) indicates that experience 
results in knowledge and understanding gained either individually or as a group or 
society through day-to-day living.  
The most immediate form of experience reported by all participants was a personal 
experience, the body of knowledge gained individually through encountering 
situations and events in this HIV/AIDS journey of life. Challenges such as a lack of 
knowledge by employers, poverty and unemployment were reported as some of the 
barriers to optimal adherence. The researcher observed during clinic visits, that 
written information and materials about adherence and treatment guidelines and 
protocols to reinforce adherence are available in the clinic. The participants 
interviewed were generally happy with the outcomes of treatment. Some participants 
72 
 
complained about side‐effects early during the treatment and the demanding nature 
of ARV regimens. Almost all participants experienced problems during the early days 
of the treatment and there were advised to stick to treatment.   
5.2.4. OBJECTIVE 4: ECONOMIC FACTORS THAT SUPPORT PEOPLE LIVING 
WITH HIV   
 
Social and economic factors may combine to yield poor adherence outcomes in 
South Africa. In addition, many patients studied experienced financial constraints for 
food and transportation to the nearest facility to collect medication, long waiting times, 
poverty and hunger, lack social support, side effects and lack of appropriate 
counseling. All these factors undermine the adherence to antiretroviral treatment 
(Kagee 2006:415) 
It is crucial to note that in this study three (60 %) of the participants reported having 
no problems adhering to their treatment whilst two (40%) agreed and admitted having 
stopped ART for more than a month prior for these interviews which is in essence 
non-adherence to treatment as it was prematurely stopped. The findings show that 
there is generally poor adherence to treatment regimes in this study.  
 
Hardon et al. (2006) conducted a study in Tanzania, Uganda and Botswana 
concludes that costs of food and transport to and from the clinic serve as a deterrent 
to ART optimal adherence. Transport costs and money for food were reported to be a 
burden for almost all respondents and a treatment‐related increase in appetite posed 
an additional challenge especially because most of the respondents are not employed 
and depend on the government grant and “piece jobs”. However, the government 
provides some nutritional support if needed in the form of nutritional supplements 
provided by the dieticians in the clinic and also a grant in the form of monetary value 
on a monthly basis depending on the status of the patients. 
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5.2.5. OBJECTIVE 5: SOCIAL FACTORS THAT SUPPORT PEOPLE LIVING WITH 
HIV 
 
According to Roura et al. (2009:48), social support is believed to affect adherence 
behaviors both directly (e.g. through positive reinforcements and encouragement) and 
indirectly (through variables that compromise adherence such as stress, anxiety and 
depression). Mukherjee et al. (2006:124) posit that social support comes in the form 
of emotional support from family, friends and peers as well as from social interactions 
in the community, including with health care providers. In addition, these factors have 
been found to have a great potential to impact on adherence to treatment.  
Furthermore, family support and religious beliefs about illness and medication may 
influence motivation and adherence. Factors such as unemployment, difficulty taking 
medication at work and dependency on social grants were reported as having 
negative bearing on adherence. It is reported in this study that two (40%) were 
unemployed and dependent on the social grants but had managed to be adherent 
with medication despite the unfavorable circumstances.  
In this study, almost all participants acknowledged the support they received from 
their immediate family members such as parents, partners and children. In addition, 
some stressed the importance of support from support groups in their communities. It 
emerged that almost all participants interviewed tended to have a good attitude 
towards their lives and good adherence to ART. 
From the study it emerged that a great many social factors play a significant role in 
determining whether patients adhere to their treatment or not. This is supported by 
Heyer and Ogunbanjo (2006:8), who suggest that personal, behavioral and 
environmental factors largely determine one’s actions. 
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5.3. WEAKNESSES AND STRENGHTS OF THE STUDY 
 
The study has some weaknesses and strengths that come out of the findings.  
5.3.1. The weaknesses of the study 
 
1) Selection bias may have occurred as only those patients who were on ART 
treatment at the time of data collection were included. The research was 
conducted among people living with HIV and who are on ART; but only those 
attending the Witpoort Hospital Wellness Clinic, in the Lephalale Local 
Municipality and who are six months and above on ART were included in the 
study. Those that were HIV positive and on ART but for less than six months and 
those who were lost to follow-up at the time of data collection were excluded. The 
findings of this study are not representative of other locations in the Lephalale 
Municipality. 
2) The use of open-ended questions in a qualitative study gives much discretion to 
researchers and participants. It was also observed that the presence of the 
researcher can potentially influence the behavior and findings of participants 
especially males. In this research only one male participant agreed to participate; 
this can compromise research findings.  
 
3) The interviews were conducted at the Wellness Clinic in the dietician consulting 
room for the convenience of both the interviewer and participants. The 
interviewers were viewed as staff members and these could lead to over-reporting 
of adherence to appease the researcher. 
5.3.2. The strengths of the study 
 
1) The study was able to meet all the objectives as outlined in the beginning which 
was to explore and investigate the knowledge, attitudes and experiences of 
people living with HIV and on ART at a public health clinic in Limpopo. 
2) The study focused mostly on the exploration of factors that influence adherence 
and non-adherence. The role and the impact that family and social support, 
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unemployment, food and knowledge of ART have on the optimal adherence of 
these patients was studied in detail. 
 
5.4. RECOMMENDATIONS FOR FURTHER RESEARCH 
 
 This study was conducted in a rural area, it is recommended that the similar study 
should be conducted in an urban area; then one would be able to compare and 
contrast the rural and urban area findings.  
 Social and economic support is an important factor in achieving optimal 
adherence. It is recommended that the role of social and economic support in 
adherence should be explored with the aim of developing improved 
implementation strategies. 
 
5.5. RECOMMENDATIONS STEMMING FROM THE FINDINGS 
 
The research involved the exploration and investigation of the knowledge, attitudes 
and experiences of people living with HIV and on Antiretroviral Treatment (ART) at 
the Witpoort Hospital Wellness Clinic. 
1) The findings suggest that patients are experiencing problems and challenges in 
their efforts to attain optimal adherence. Conclusions by the researcher were 
made that these might be some of the challenges and factors causing patients to 
become lost to follow-up. It was shown through interviews of the participants that 
transport and food costs, lack of proper counseling, poverty are some of obstacles 
to optimal adherence.  ART programmes need to find ways to confront these 
constraints. 
2) Treatment programmes also urgently need to find ways to reduce waiting times for 
ART patients coming for refills and take into consideration the work schedules of 
ART users.  
3) Pharmacists and nurses can play an important role in this follow‐up care. Their 
involvement can also reduce the workload of doctors. To provide good quality 
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care, all auxiliary health workers should be trained to recognize clinical signs of 
treatment failure, such as emergent opportunistic infections, and to provide 
adequate adherence support. It is recommended that task shifting from 
pharmacists to auxiliary health workers should be explored. 
4) Adequate counseling services are needed at health facilities or in communities in 
both the initiation and continuation phases of ART to help patients cope with the 
side effects of ART, identify and confront the social constraints to adherence, and 
address the financial problems that ART patients face. Training programmes for 
counselors and people taking ART are limited. It is recommended that adequate 
counseling should be explored with the objectives of developing implementation 
plans and strategies. 
5) Programmes for ART adherence counseling exist in South Africa and could be 
used more fully. More specifically, adherence support programmes need to find 
ways to help ART patients to remember to take their pills on time, for example 
through alarms on mobile phones, or through using popular radio programmes as 
a prompt. Adherence support could recognize the potential role of children in 
adherence support, and provide them with adequate information on ART, for 
example through school education programmes, to empower them in their role as 
treatment supporters. Who then becomes a treatment supporter?  
 
5.6. CONCLUSION 
 
The aim of this study was to investigate the knowledge, attitudes and experiences of 
people living with HIV and on ART at the Witpoort Hospital, Limpopo Province. It is 
envisaged that the findings of this study will help the health care professionals and 
the Provincial Department of Health to develop intervention strategies and 
programmes that will help in identifying those patients at risk of non-adhering to 
treatment and those that need support for optimal adherence. The most commonly 
reported experiences on ART in this study were inability to take treatment at work, 
being just too lazy to go to clinic for follow-up visits and forgetting to take the 
treatment. It also emerged that a lack of HIV and AIDS knowledge of the employers 
and colleagues contributed to some participants not adhering to their treatment. 
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ANNEXURE A: INFORMED CONSENT FOR PARTICIPANTS 
You will be asked to participate in interviews for the study research. The researcher 
would like to hear about your knowledge, attitudes and experiences of your ARV 
treatment. The reason why the researcher would like to gather this information is to 
improve the existing services. The researcher will not record your name anywhere 
and no one will be able to link you to the answers you give.  
There will be one interviewer. The interview is confidential, with no correct or incorrect 
answers. You are allowed to refuse answering any questions that makes you feel 
uncomfortable. The interview will last around 30 minutes – one hour. The interviewer 
will be asking you a few questions and request that you are as open and honest as 
possible in answering these questions. If the interviewer ask you a question which 
makes you feel sad or upset, we can stop and talk about it. 
A tape recorder will be used to record information you’re giving the interviewer. All the 
information and records about your answers will be kept confidential, only the 
researcher will have access to this information. Your decision to participate is 
voluntary. You have the right to withdraw at any given point. You will only be identified 
by a code number and the information will be destroyed after the study has been 
conducted and the results written up. No direct benefits will be given to you, but your 
contribution will benefit others in the future by helping to improve support for people 
receiving ARV treatment.  If you have any concerns or problems after the interview. 
You are welcome to contact the researcher at the following details: 
Mulelu Rodney - Cell: 072 794 9825 - Email: Mulelur@yahoo.com 
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ANNEXURE B: INTERVIEW GUIDE FOR PARTICIPANTS 
Participant No: ________________________ 
Instructions 
Interviews will only commence after having read the informed consent and 
information sheet and the participant understood and consented to be interviewed. 
SECTION A:  Demographic information 
1. Gender 
Male  
Female  
 
 
2. Age 
Younger than 30 
years 
30 - 39 years 40 years and older 
   
 
 
3. Marital Status 
Single  
Married  
Divorced  
Separated  
Widowed  
 
 
4. Current place of residence 
Seleka  
Thabo Mbeki  
Libu  
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5. Place of residence in a Rural or Urban area 
Urban   
Rural  
 
 
6. Educational level 
None Primary Secondary 
   
 
 
7. Home Language 
Sepedi  
Tswana  
Zulu  
 
 
8. Current employment status 
Employed Not employed 
  
 
9. Main source of income 
Salary Pension after having been medically 
boarded 
No income 
   
 
SECTION B: Investigate the knowledge that PLHIV have on ART 
1. What do you know about antiretroviral therapy? 
2. What ARVs do to a human body in your own words? 
3. What are the names of ARVs you are taking? 
4. Were you provided with information regarding ARVs? What information? Is the 
information helpful? Why? 
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SECTION C: Identify attitude of PLHIV towards Antiretroviral Treatment 
1. What are your feelings towards taking ARVs? 
2. Do you think they help? Do people against ARV’s? Why they are against it? Will it 
cure them? Does it make them sick? 
3. Why did you decide to start on ARVs? 
4. Can you advise other people to take the treatment? Why? 
 
SECTION D: Identify experiences of PLHIV of Antiretroviral treatment 
1. Before you started the treatment, how was life?  
2. How long after you discovered that you are HIV positive did you start the ARVs? 
3. When / where did you first hear of ARVs? How did you react at that stage? Were 
you happy / unhappy? Why? 
4. What is your experience on ART? Are you better or worse than before you start 
the treatment? 
5. How did you get started on taking ARVs? How easy or difficult was it? Explain 
why? 
6. How do ARVs affect you as a person? 
7. Was the issue of adherence discussed when you started the treatment?  
8. How do you understand ‘adherence’ in your own words? 
9. Why is adherence important when taking ARV’s? 
10. Did you ever miss or stop taking your medication? E.g. have you ever missed a 
dose in the last week or a month? 
11. What do you think is the cause of this? 
12. What is the most difficult dose of the day?  
13. How did you feel when you missed a dose? 
SECTION E: Identify economic factors that support PLHIV 
1. Are you earning an income at the moment? How? If not how do you spend your 
days?  
2. Who provides the main financial support at home? 
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3. Do you have electricity at home? Tap water? TV? Radio? A car?  
4. Are the existing economic and social services helpful for people living with HIV 
and AIDS? 
SECTION F: Identify social factors that support PLHIV 
1. Have you told anyone about your HIV status, for example, friends, children, 
spouse (sexual partner) and parents? 
2. How did she/he react? 
3. Who else are you willing to disclose to? 
4. Who is supporting and assisting you not to forget treatment and reminding you to 
go to clinic for follow-up? 
5. Do you belong to a support group in your community? 
6. If you have a problem with ARVs, did you ever speak to somebody or your nurse 
or a doctor about your problem? Were they helpful? 
7. From your experience, what do you think people on ARVs need in terms of 
support that will be helpful to them? 
8. What do you think about your nurse and your doctor? Are you happy with them? 
Why? 
 
Thank you for your time 
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ANNEXURE C: REQUEST PERMISSION TO CONDUCT RESEARCH: LDOH 
Witpoort Hospital 
Lephalale 
0555 
02 September 2013 
The Research Manager  
Department of Health 
Polokwane 
0700 
 
Dear Sir / Madam  
 
RE: REQUEST PERMISSION TO CONDUCT RESEARCH: STUDENT NUMBER:  
362-1-9835 
 
I, Rodney Azwinndini Mulelu, Identity Number: 7211106204080, Persal number: 
90840909, hereby wish to apply for a permission to conduct research study in the 
Wellness (ARV) clinic at Witpoort Hospital.  I’m currently working for Department of 
Health – Limpopo based at Witpoort Hospital as an Assistant Director: Dietetics and 
I’m studying towards a Master’s degree in Social behavior in HIV and AIDS with 
UNISA. 
My study is entitled “Knowledge, attitudes and experiences of people living with 
HIV and on antiretroviral treatment at a public health clinic, in Limpopo 
Province, South Africa. I will be interviewing 5 to 10 people taking ARVs at Witpoort 
Hospital. I’m enclosing my copy of the research proposal and the interview guide. I’ll 
appreciate your timeous response as your permission is one of the requirements for 
ethical approval of my proposal.  
Thanking you in advance.  
Kind Regards 
__________________________ 
Mr. Rodney Azwinndini Mulelu 
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ANNEXURE D: REQUEST PERMISSION TO CONDUCT RESEARCH: UNISA 
Witpoort Hospital 
Lephalale 
0555 
04 September 2013 
Ms. Elize Koen 
SUPERVISOR 
UNIVERSITY OF SOUTH AFRICA (UNISA) 
PRETORIA 
0001 
 
Dear Sir / Madam  
 
RE: REQUEST FOR RENEWAL PERMISSION TO CONDUCT RESEARCH: 
STUDENT NUMBER: 362-1-9835 
 
I, Rodney Azwinndini Mulelu, Identity Number: 7211106204080, Persal number: 
90840909 hereby wish to apply for a permission to conduct research study in the 
Wellness (ARV) clinic at Witpoort Hospital.  I’m currently working for Department of 
Health – Limpopo based at Witpoort Hospital as an Assistant Director: Dietetics and 
I’m studying towards a Master’s degree in Social behavior in HIV and AIDS with 
UNISA. 
My study is entitled “knowledge, attitude and experiences of people living with 
HIV and on antiretroviral treatment at a public health clinic, in Limpopo 
Province, South Africa. I will be interviewing 5 to 10 people taking ARVs at Witpoort 
Hospital. 
I’ll appreciate your timeous response as your permission will allow me to continue 
with my research on time. 
 
Thanking you in advance.  
 
Kind Regards 
____________________________ 
Mr. Rodney Azwinndini Mulelu 
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ANNEXURE E: APPROVAL TO CONDUCT RESEARCH: UNISA 
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ANNEXURE F: APPROVAL TO CONDUCT RESEARCH: LDOH 
 
